UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-34581

 

  

logo

KRATON PERFORMANCE POLYMERS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

20-0411521

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

15710 John F. Kennedy Blvd.

Suite 300

Houston, TX 77032

281-504-4700

(Address of principal executive offices, including zip code)

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act. (Check one):

 

Large accelerated filer:

x

Accelerated filer:

¨

Non-accelerated filer:

¨

Smaller reporting company:

¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

Number of shares of Kraton Performance Polymers, Inc. Common Stock, $0.01 par value, outstanding as of April 24, 2014: 32,777,278.

 

 

 

 


 

Index to Quarterly Report

on Form 10-Q for

Quarter Ended March 31, 2014

 

 

PART I. FINANCIAL INFORMATION

Page

Item 1

  

Condensed Consolidated Financial Statements (Unaudited)

7

 

  

Condensed Consolidated Balance Sheets as of March 31, 2014 and December 31, 2013

7

 

  

Condensed Consolidated Statements of Operations for the three months ended March 31, 2014 and 2013

8

 

  

Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2014 and 2013

9

 

  

Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2014 and 2013

10

 

  

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2014 and 2013

11

 

  

Notes to the Condensed Consolidated Financial Statements

12

Item 2

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

34

Item 3

  

Quantitative and Qualitative Disclosures About Market Risk

46

Item 4

  

Controls and Procedures

46

PART II. OTHER INFORMATION

 

Item 1

  

Legal Proceedings

47

Item 1A

  

Risk Factors

47

Item 6

  

Exhibits

48

 

  

Signatures

49

 

 

 

2


 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Some of the statements in this Quarterly Report on Form 10-Q under the headings “Condensed Consolidated Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We may also make written or oral forward-looking statements in our periodic reports on Forms 10-K, 10-Q and 8-K, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “believes,” “estimates,” “expects,” “projects,” “may,” “intends,” “plans” or “anticipates,” or by discussions of strategy, plans or intentions; anticipated benefits of or performance of our products; beliefs regarding opportunities for new, high-margin applications and other innovations; adequacy of cash flows to fund our working capital requirements; our investment in the joint venture with Formosa Petrochemical Corporation (“FPCC”); our expectations regarding indebtedness to be incurred by our joint venture with FPCC; our proposed combination with the styrenic block copolymer (“SBC”) business of LCY Chemical Corp. (“LCY”), the expectation that such combination will close in the fourth quarter of 2014 and expected synergies and other benefits therefrom and costs associated therewith; our ability to obtain a consent under the indenture governing our 6.75% senior notes in connection with our proposed combination with the SBC business of LCY; debt payments, interest payments, capital expenditures, benefit plan contributions, and income tax obligations; our anticipated 2014 capital expenditures, compliance with the MACT rule, health, safety and environmental and infrastructure and maintenance projects, projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform; our ability to ensure full access to our senior secured credit facilities; expectations regarding our counterparties’ ability to perform, including with respect to trade receivables; estimates regarding the tax expense of repatriating certain cash and short-term investments related to foreign operations; expectations regarding high-margin applications; our ability to realize certain deferred tax assets and our beliefs with respect to tax positions; expectations regarding our full year effective tax rate; our plans and expectations regarding our Asia expansion project; estimates related to the useful lives of certain assets for tax purposes; expectations regarding our pension contributions for fiscal year 2014; estimates or expectations related to monomer costs, ending inventory levels and related estimated charges; the outcome and financial impact of legal proceedings; expectations regarding the spread between FIFO and ECRC in future periods; and projections regarding environmental costs and capital expenditures and related operational savings. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Further description of these risks and uncertainties and other important factors are set forth in this report, in our latest Annual Report on Form 10-K, including but not limited to “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, and in our other filings with the Securities and Exchange Commission, and include, but are not limited to, risks related to:

the likelihood of closing the combination with LCY, which is subject to a number of material regulatory conditions;

the business uncertainties and contractual restrictions that we and LCY are subject to while the proposed LCY Combination is pending, which could adversely affect each party’s business and operations;

failure to successfully combine the businesses in the expected time frame may adversely affect the future results of the combined organization, and, consequently, the value of our common stock;

failure to complete the LCY Combination, or significant delays in completing the LCY Combination, could negatively affect the trading price of our common stock and our future business and financial results;

the possibility that we may not realize the benefits we anticipate from the proposed redomestication of our company from Delaware to the United Kingdom;

our reliance on LyondellBasell Industries for the provision of significant operating and other services;

conditions in the global economy and capital markets;

the failure of our raw materials suppliers to perform their obligations under long-term supply agreements, or our inability to replace or renew these agreements when they expire;

3


 

limitations in the availability of raw materials we need to produce our products in the amounts or at the prices necessary for us to effectively and profitably operate our business;

significant fluctuations in raw material costs may result in volatility in our quarterly operating results and impact the market price of our common stock;

competition in our end use markets by other producers of styrenic block copolymers and by producers of products that can be substituted for our products;

our ability to produce and commercialize technological innovations;

our ability to protect our intellectual property, on which our business is substantially dependent;

the possibility that our products infringe upon the intellectual property rights of others;

a major failure of our information systems, which could harm our business;

seasonality in our business, particularly in our Paving and Roofing end use market;

our substantial indebtedness, which could adversely affect our financial condition and prevent us from fulfilling our obligations under the senior secured credit facilities and the senior notes;

financial and operating constraints related to our indebtedness;

the inherently hazardous nature of chemical manufacturing;

product liability claims and other lawsuits arising from environmental damage, personal injuries, other damages associated with chemical manufacturing or our products;

political, economic and local business risks in the various countries in which we operate;

health, safety and environmental laws, including laws that govern our employees’ exposure to chemicals deemed harmful to humans;

regulation of our company or our customers, which could affect the demand for our products or result in increased compliance and other costs;

customs, international trade, export control, antitrust, zoning and occupancy and labor and employment laws that could require us to modify our current business practices and incur increased costs;

fluctuations in currency exchange rates;

we may have additional tax liabilities;

our formation of a joint venture to expand HSBC capacity in Asia;

our relationship with our employees;

loss of key personnel or our inability to attract and retain new qualified personnel;

the fact that we generally do not enter into long-term contracts with our customers;

a decrease in the fair value of our pension assets could require us to materially increase future funding requirements of the pension plan;

domestic or international natural disasters or terrorist attacks may disrupt our operations;

Delaware law and some provisions of our organizational documents that make a takeover of our company more difficult;

our expectation that we will not pay dividends for the foreseeable future; and

we are a holding company with nominal net worth and will depend on dividends and distributions from our subsidiaries to pay any dividends.

4


 

There may be other factors of which we are currently unaware or that we deem immaterial that may cause our actual results to differ materially from the expectations we express in our forward-looking statements. Although we believe the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and, therefore, also the forward-looking statements based on these assumptions could themselves prove to be inaccurate.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them publicly in light of new information or future events.

Presentation of Financial Statements

The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

This Form 10-Q includes financial statements and related notes that present the condensed consolidated financial position, results of operations, comprehensive income, and cash flows of Kraton and its subsidiaries. Kraton is a holding company whose only material asset is its investment in its wholly owned subsidiary, Kraton Polymers LLC. Kraton Polymers LLC and its subsidiaries own all of our consolidated operating assets.

 

 

 

5


 

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Kraton Performance Polymers, Inc.:

We have reviewed the accompanying condensed consolidated balance sheet of Kraton Performance Polymers, Inc. and subsidiaries (the Company) as of March 31, 2014, and the related condensed consolidated statements of operations, comprehensive loss, changes in equity, and cash flows for the three-month periods ended March 31, 2014 and 2013. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2013, and the related consolidated statements of operations, comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 27, 2014, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2013 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

/s/ KPMG LLP

Houston, Texas
May 1, 2014

 

 

 

6


 

PART I. FINANCIAL INFORMATION

Item 1.

Condensed Consolidated Financial Statements.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except par value)

 

 

March 31,

 

 

December 31,

 

 

2014

 

 

2013

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

97,319

 

 

$

175,872

 

Receivables, net of allowances of $402 and $315

 

150,848

 

 

 

129,356

 

Inventories of products

 

343,511

 

 

 

328,772

 

Inventories of materials and supplies

 

11,261

 

 

 

10,947

 

Deferred income taxes

 

9,764

 

 

 

7,596

 

Other current assets

 

20,234

 

 

 

20,665

 

Total current assets

 

632,937

 

 

 

673,208

 

Property, plant and equipment, less accumulated depreciation of $367,223 and $353,428

 

433,817

 

 

 

414,257

 

Intangible assets, less accumulated amortization of $81,489 and $78,784

 

55,696

 

 

 

57,488

 

Investment in unconsolidated joint venture

 

13,721

 

 

 

14,074

 

Debt issuance costs

 

8,642

 

 

 

9,213

 

Deferred income taxes

 

1,452

 

 

 

1,326

 

Other long-term assets

 

25,738

 

 

 

25,231

 

Total assets

$

1,172,003

 

 

$

1,194,797

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current portion of long-term debt

$

2,996

 

 

$

0

 

Accounts payable-trade

 

101,319

 

 

 

115,736

 

Other payables and accruals

 

43,256

 

 

 

54,539

 

Deferred income taxes

 

183

 

 

 

182

 

Due to related party

 

26,295

 

 

 

24,603

 

Total current liabilities

 

174,049

 

 

 

195,060

 

Long-term debt, net of current portion

 

351,975

 

 

 

350,989

 

Deferred income taxes

 

18,232

 

 

 

18,359

 

Other long-term liabilities

 

76,605

 

 

 

75,991

 

Total liabilities

 

620,861

 

 

 

640,399

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

Kraton stockholders' equity:

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized; 32,774 shares issued and outstanding at March 31, 2014; 32,547 shares issued and outstanding at December 31, 2013

 

328

 

 

 

325

 

Additional paid in capital

 

367,307

 

 

 

363,590

 

Retained earnings

 

162,918

 

 

 

170,827

 

Accumulated other comprehensive loss

 

(19,453

)

 

 

(21,252

)

Total Kraton stockholders' equity

 

511,100

 

 

 

513,490

 

Noncontrolling interest

 

40,042

 

 

 

40,908

 

Total equity

 

551,142

 

 

 

554,398

 

Total liabilities and equity

$

1,172,003

 

 

$

1,194,797

 

See Notes to Condensed Consolidated Financial Statements

7


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

Sales revenue

$

311,656

 

 

$

340,107

 

Cost of goods sold

 

254,583

 

 

 

280,196

 

Gross profit

 

57,073

 

 

 

59,911

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

8,297

 

 

 

7,913

 

Selling, general and administrative

 

34,218

 

 

 

26,114

 

Depreciation and amortization

 

16,409

 

 

 

15,098

 

Total operating expenses

 

58,924

 

 

 

49,125

 

Earnings of unconsolidated joint venture

 

117

 

 

 

134

 

Interest expense, net

 

6,338

 

 

 

13,298

 

Loss before income taxes

 

(8,072

)

 

 

(2,378

)

Income tax expense

 

122

 

 

 

1,446

 

Consolidated net loss

 

(8,194

)

 

 

(3,824

)

Net loss attributable to noncontrolling interest

 

(285

)

 

 

(76

)

Net loss attributable to Kraton

$

(7,909

)

 

$

(3,748

)

Loss per common share:

 

 

 

 

 

 

 

Basic

 

(0.24

)

 

 

(0.12

)

Diluted

 

(0.24

)

 

 

(0.12

)

Weighted average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

32,162

 

 

 

32,062

 

Diluted

 

32,162

 

 

 

32,062

 

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

 

8


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

Net loss attributable to Kraton

$

(7,909

)

 

$

(3,748

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax of $0

 

1,799

 

 

 

(9,271

)

Unrealized gain of interest rate swap, net of tax of $0

 

 

 

 

837

 

Unrealized loss of net investment hedge, net of tax of $0

 

 

 

 

(225

)

Other comprehensive income (loss), net of tax

 

1,799

 

 

 

(8,659

)

Comprehensive loss attributable to Kraton

 

(6,110

)

 

 

(12,407

)

Comprehensive income (loss) attributable to noncontrolling interest

 

(866

)

 

 

224

 

Consolidated comprehensive loss

$

(6,976

)

 

$

(12,183

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

9


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)

(In thousands)

 

 

Common Stock

 

 

 

Additional Paid in Capital

 

 

Retained Earnings

 

 

Accumulated Other Comprehensive Income (Loss)

 

 

Total Kraton Stockholders' Equity

 

 

Noncontrolling Interest

 

 

Total Equity

 

Balance at December 31, 2012

$

323

 

 

$

354,957

 

 

$

171,445

 

 

$

(34,510

)

 

$

492,215

 

 

$

 

 

$

492,215

 

Net loss

 

 

 

 

 

 

 

(3,748

)

 

 

 

 

 

(3,748

)

 

 

(76

)

 

 

(3,824

)

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

(8,659

)

 

 

(8,659

)

 

 

300

 

 

 

(8,359

)

Consolidation of variable interest entity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,174

 

 

 

15,174

 

Exercise of stock options

 

2

 

 

 

308

 

 

 

 

 

 

 

 

 

310

 

 

 

 

 

 

310

 

Non-cash compensation related to equity awards

 

 

 

 

2,523

 

 

 

 

 

 

 

 

 

2,523

 

 

 

 

 

 

2,523

 

Balance at March 31, 2013

$

325

 

 

$

357,788

 

 

$

167,697

 

 

$

(43,169

)

 

$

482,641

 

 

$

15,398

 

 

$

498,039

 

Balance at December 31, 2013

$

325

 

 

$

363,590

 

 

$

170,827

 

 

$

(21,252

)

 

$

513,490

 

 

$

40,908

 

 

$

554,398

 

Net loss

 

 

 

 

 

 

 

(7,909

)

 

 

 

 

 

(7,909

)

 

 

(285

)

 

 

(8,194

)

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

1,799

 

 

 

1,799

 

 

 

(581

)

 

 

1,218

 

Retired treasury stock

 

 

 

 

(429

)

 

 

 

 

 

 

 

 

(429

)

 

 

 

 

 

(429

)

Exercise of stock options

 

1

 

 

 

534

 

 

 

 

 

 

 

 

 

535

 

 

 

 

 

 

535

 

Non-cash compensation related to equity awards

 

2

 

 

 

3,612

 

 

 

 

 

 

 

 

 

3,614

 

 

 

 

 

 

3,614

 

Balance at March 31, 2014

$

328

 

 

$

367,307

 

 

$

162,918

 

 

$

(19,453

)

 

$

511,100

 

 

$

40,042

 

 

$

551,142

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

10


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

Three months ended March 31,

 

 

2014

 

 

2013

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Consolidated net loss

$

(8,194

)

 

$

(3,824

)

Adjustments to reconcile consolidated net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

16,409

 

 

 

15,098

 

Amortization of debt premium

 

(40

)

 

 

(38

)

Amortization of debt issuance costs

 

553

 

 

 

5,781

 

Gain on property, plant and equipment

 

(17

)

 

 

(16

)

Earnings from unconsolidated joint venture, net of dividends received

 

370

 

 

 

288

 

Deferred income tax benefit

 

(2,393

)

 

 

(921

)

Share-based compensation

 

3,614

 

 

 

2,523

 

Decrease (increase) in:

 

 

 

 

 

 

 

Accounts receivable

 

(20,748

)

 

 

(32,078

)

Inventories of products, materials and supplies

 

(14,300

)

 

 

(14,148

)

Other assets

 

573

 

 

 

(588

)

Increase (decrease) in:

 

 

 

 

 

 

 

Accounts payable-trade

 

(24,362

)

 

 

12,926

 

Other payables and accruals

 

(6,617

)

 

 

(15,767

)

Other long-term liabilities

 

582

 

 

 

2,196

 

Due to related party

 

983

 

 

 

7,794

 

Net cash used in operating activities

 

(53,587

)

 

 

(20,774

)

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

(20,185

)

 

 

(14,455

)

Purchase of software and other intangibles

 

(1,062

)

 

 

(707

)

Settlement of net investment hedge

 

 

 

 

(2,225

)

Net cash used in investing activities

 

(21,247

)

 

 

(17,387

)

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

Proceeds from debt

 

 

 

 

40,000

 

Repayments of debt

 

 

 

 

(96,875

)

Capital lease payments

 

(3,011

)

 

 

(950

)

Contribution from noncontrolling interest

 

 

 

 

15,174

 

Purchase of treasury stock

 

(429

)

 

 

 

Proceeds from the exercise of stock options

 

535

 

 

 

310

 

Debt issuance costs

 

 

 

 

(3,117

)

Net cash used in financing activities

 

(2,905

)

 

 

(45,458

)

Effect of exchange rate differences on cash

 

(814

)

 

 

(3,429

)

Net decrease in cash and cash equivalents

 

(78,553

)

 

 

(87,048

)

Cash and cash equivalents, beginning of period

$

175,872

 

 

 

223,166

 

Cash and cash equivalents, end of period

$

97,319

 

 

$

136,118

 

Supplemental disclosures:

 

 

 

 

 

 

 

Cash paid during the period for income taxes, net of refunds received

$

2,293

 

 

$

4,643

 

Cash paid during the period for interest, net of capitalized interest

$

11,608

 

 

$

13,639

 

Capitalized interest

$

636

 

 

$

961

 

Supplemental non-cash disclosures:

 

 

 

 

 

 

 

Property, plant and equipment accruals

$

15,168

 

 

$

3,495

 

Asset acquired through capital lease

$

7,033

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

 

11


 

KRATON PERFORMANCE POLYMERS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Description of our Business. We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability. 

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than more commoditized products. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products such as disposable diapers and the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms.

We have a portfolio of innovations at various stages of development and commercialization, including

polyvinyl chloride alternatives for wire and cable and medical applications;

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

highly-modified asphalt (“HiMA”) for high-performance paving applications;

NEXAR family of membrane polymers for water filtration, heating, ventilation, air conditioning and breathable fabrics; and

synthetic cement formulations and other oilfield applications.

We manufacture our polymers at five manufacturing facilities globally, including our flagship facility in Belpre, Ohio, as well as facilities in Germany, France, Brazil and Japan. The facility in Japan is operated by an unconsolidated manufacturing joint venture. The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements presented herein are for us and our consolidated subsidiaries, each of which is a wholly-owned subsidiary, except our 50% investment in our joint venture, Kraton Formosa Polymers Corporation (“KFPC”), located in Mailiao, Taiwan. KFPC is a variable interest entity for which we have determined that we are the primary beneficiary and, therefore, have consolidated into our financial statements. Our 50% investment in our joint venture located in Kashima, Japan is accounted for under the equity method of accounting. All significant intercompany transactions have been eliminated. These interim financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013 and reflect all normal recurring adjustments that are, in the opinion of management, necessary to present fairly our results of operations and financial position. Amounts reported in our Condensed Consolidated Statements of Operations are not necessarily indicative of amounts expected for the respective annual periods or any other interim period, in particular due to the effect of seasonal changes and weather conditions that typically affect our sales into our Paving and Roofing end use market.

12


 

Our significant accounting policies have been disclosed in Note 1 Description of Business, Basis of Presentation and Significant Accounting Policies in our most recent Annual Report on Form 10-K. There have been no changes to the policies disclosed therein. The accompanying unaudited condensed consolidated financial statements we present in this report have been prepared in accordance with those policies.

Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include

the useful lives of fixed assets;

allowances for doubtful accounts and sales returns;

the valuation of derivatives, deferred tax assets, property, plant and equipment, inventory, investments and share-based compensation; and

liabilities for employee benefit obligations, environmental matters, asset retirement obligations (“ARO”), income tax uncertainties and other contingencies.

Income Tax in Interim Periods. We conduct operations in separate legal entities in different jurisdictions. As a result, income tax amounts are reflected in these condensed consolidated financial statements for each of those jurisdictions. Tax laws and tax rates vary substantially in these jurisdictions and are subject to change based on the political and economic climate in those countries. We file our tax returns in accordance with our interpretations of each jurisdiction’s tax laws. We record our tax provision or benefit on an interim basis using the estimated annual effective tax rate. This rate is applied to the current period ordinary income or loss to determine the income tax provision or benefit allocated to the interim period.

Losses from jurisdictions for which no benefit can be realized and the income tax effects of unusual and infrequent items are excluded from the estimated annual effective tax rate. Valuation allowances are provided against the future tax benefits that arise from the losses in jurisdictions for which no benefit can be realized. The effects of unusual and infrequent items are recognized in the impacted interim period as discrete items.

The estimated annual effective tax rate may be significantly affected by nondeductible expenses and by our projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period during which such estimates are revised.

We have established valuation allowances against a variety of deferred tax assets, including net operating loss carryforwards, foreign tax credits and other income tax credits. Valuation allowances take into consideration our expected ability to realize these deferred tax assets and reduce the value of such assets to the amount that is deemed more likely than not to be recoverable. Our ability to realize these deferred tax assets is dependent on achieving our forecast of future taxable operating income over an extended period of time. We review our forecast in relation to actual results and expected trends on a quarterly basis. If we fail to achieve our operating income targets, we may change our assessment regarding the recoverability of our net deferred tax assets and such change could result in a valuation allowance being recorded against some or all of our net deferred tax assets. A change in our valuation allowance would impact our income tax expense/benefit and our stockholders’ equity and could have a significant impact on our results of operations or financial condition in future periods.

 

13


 

2. New Accounting Pronouncements

Adoption of Accounting Standards

We have implemented all new accounting pronouncements that are in effect and that management believes would materially affect our financial statements. Management does not believe that there are any other new accounting pronouncements that have been issued that may have a material impact on our financial position or results of operations.

 

3. Share-Based Compensation

We account for share-based awards under the provisions of ASC 718, “Compensation—Stock Compensation.” Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award and we expense these costs using the straight-line method over the requisite service period. Share-based compensation expense was $3.6 million and $2.5 million for the three months ended March 31, 2014 and 2013, respectively. We have historically recorded these costs in selling, general and administrative expenses; however, beginning in the second quarter of 2013, a portion of these costs were recorded in cost of goods sold and research and development expenses.

 

4. Detail of Certain Balance Sheet Accounts

 

 

 

March 31,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Inventories of products:

 

 

 

 

 

 

 

Finished products

$

256,997

 

 

$

246,758

 

Work in progress

 

6,045

 

 

 

5,384

 

Raw materials

 

80,469

 

 

 

76,630

 

Total inventories of products

$

343,511

 

 

$

328,772

 

Other payables and accruals:

 

 

 

 

 

 

 

Employee related

$

11,883

 

 

$

16,066

 

Other

 

31,373

 

 

 

38,473

 

Total other payables and accruals

$

43,256

 

 

$

54,539

 

Other long-term liabilities:

 

 

 

 

 

 

 

Pension and other postretirement benefits

$

58,152

 

 

$

57,924

 

Other

 

18,453

 

 

 

18,067

 

Total other long-term liabilities

$

76,605

 

 

$

75,991

 

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

Foreign currency translation adjustments

$

24,557

 

 

$

22,758

 

Net unrealized loss on net investment hedge

 

(1,926

)

 

 

(1,926

)

Pension liability

 

(42,084

)

 

 

(42,084

)

Total accumulated other comprehensive loss

$

(19,453

)

 

$

(21,252

)

 

 

 

5. Earnings Per Share (“EPS”)

Basic EPS is computed by dividing net income attributable to Kraton by the weighted-average number of shares outstanding during the period.

Diluted EPS is computed by dividing net income attributable to Kraton by the diluted weighted-average number of shares outstanding during the period and, accordingly, reflects the potential dilution that could occur if securities or other agreements to issue common stock, such as stock options, were exercised, settled or converted into common stock and were dilutive. The diluted weighted-average number of shares used in our diluted EPS calculation is determined using the treasury stock method.

Unvested awards of share-based payments with rights to receive dividends or dividend equivalents, such as our restricted stock awards are considered to be participating securities and therefore the two-class method is used for purposes of calculating EPS. Under

14


 

the two-class method, a portion of net income is allocated to these participating securities and therefore is excluded from the calculation of EPS allocated to common stock. Our restricted stock awards are subject to forfeiture and restrictions on transfer until vested and have identical voting, income and distribution rights to the unrestricted common shares outstanding. Our weighted average restricted stock awards outstanding were 458,319 and 294,317 for the three months ended March 31, 2014 and 2013, respectively. For the three months ended March 31, 2014, we withheld 15,707 shares of restricted stock upon vesting to satisfy employee payroll tax withholding requirements. We immediately retired all shares withheld and the transactions were reflected in additional paid in capital in the Condensed Consolidated Statements of Changes in Equity and as a purchase of treasury stock in the Condensed Consolidated Statements of Cash Flows.

For the three months ended March 31, 2014 and 2013, the weighted average restricted share units of 66,973 and 37,921, respectively, are not included as a component of diluted EPS as they are anti-dilutive.  

The weighted average performance share units of 100,861 and 20,276 are not included as a component of diluted EPS as they are anti-dilutive for the three months ended March 31, 2014 and 2013, respectively.

The computation of diluted earnings per share excludes the effect of the potential exercise of stock options that are anti-dilutive. The number of stock options excluded from the computation was 1,711,814 and 1,643,950 for the three months ended March 31, 2014 and 2013, respectively.

The effects of share-based compensation awards on the diluted weighted-average number of shares outstanding used in calculating diluted EPS are as follows:

 

 

Three months ended March 31, 2014

 

 

Three months ended March 31, 2013

 

 

Net Loss
Attributable
to Kraton

 

 

Weighted
Average
Shares
Outstanding

 

 

Loss Per Share

 

 

Net Loss
Attributable
to Kraton

 

 

Weighted
Average
Shares
Outstanding

 

 

Loss Per Share

 

 

(In thousands, except per share data)

 

 

(In thousands, except per share data)

 

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As reported

$

(7,909

)

 

 

32,620

 

 

 

 

 

 

$

(3,748

)

 

 

32,356

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

111

 

 

 

(458

)

 

 

 

 

 

 

34

 

 

 

(294

)

 

 

 

 

Amounts available to common stockholders

 

(7,798

)

 

 

32,162

 

 

$

(0.24

)

 

 

(3,714

)

 

 

32,062

 

 

$

(0.12

)

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts allocated to unvested restricted shares

 

(111

)

 

 

458

 

 

 

 

 

 

 

(34

)

 

 

294

 

 

 

 

 

Non participating share units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options added under the treasury stock method

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts reallocated to unvested restricted shares

 

111

 

 

 

(458

)

 

 

 

 

 

 

34

 

 

 

(294

)

 

 

 

 

Amounts available to stockholders and assumed conversions

$

(7,798

)

 

 

32,162

 

 

$

(0.24

)

 

$

(3,714

)

 

 

32,062

 

 

$

(0.12

)

 

15


 

6. Long-Term Debt

Long-term debt consists of the following:

 

 

March 31,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

6.75% unsecured notes

$

350,949

 

 

$

350,989

 

Capital lease obligation

 

4,022

 

 

 

 

Total debt

 

354,971

 

 

 

350,989

 

Less current portion of total debt

 

2,996

 

 

 

 

Long-term debt

$

351,975

 

 

$

350,989

 

 

 

Senior Secured Credit Facilities. In March 2013, we entered into an asset-based revolving credit facility consisting of a $150.0 million U.S. senior secured revolving credit facility and a $100.0 million Dutch senior secured revolving credit facility (the “Senior Secured Credit Facilities”). The Senior Secured Credit Facilities replaced our then existing senior secured credit facility, and we repaid in full all outstanding amounts payable under the previously existing indebtedness. Borrowing under the Senior Secured Credit Facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security.

We may request up to an aggregate of $100.0 million of additional revolving facility commitments of which up to an aggregate of $40.0 million may be additional Dutch revolving facility commitments, provided that we satisfy additional conditions described in the Senior Secured Credit Facilities, and provided further that the U.S. revolver commitment is at least 60% of the commitments after giving effect to such increase.

Kraton Polymers U.S. LLC and Kraton Polymers Nederland B.V. are the borrowers under the Senior Secured Credit Facilities, and Kraton Performance Polymers, Inc., Kraton Polymers LLC, Elastomers Holdings LLC and Kraton Polymers Capital Corporation are guarantors. The Senior Secured Credit Facilities are secured by receivables and inventory. The Senior Secured Credit Facilities terminate on March 27, 2018; however, we may from time to time request that the lenders extend the maturity of their commitments. Availability under the Senior Secured Credit Facilities is limited to the lesser of the borrowing base and total commitments (less certain reserves).

U.S. borrowings under the Senior Secured Credit Facilities (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% and (3) LIBOR plus 1.0%, or (b) a rate based on LIBOR, in each case plus an applicable margin. U.S. swingline loans shall bear interest at a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% or (3) LIBOR plus 1.0%, in each case plus an applicable margin.

Dutch borrowings under the Senior Secured Credit Facilities bear interest at a rate equal to, at the applicable borrower’s option, either (a) a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded, or (b) a rate based on LIBOR, in each case plus an applicable margin.

The applicable margin is subject to a minimum of 0.5% and a maximum of 1.0% with respect to U.S. base rate loans, and a minimum of 1.5% and maximum of 2.0% for foreign base rate borrowings and LIBOR loans and is subject to adjustment based on the borrowers’ excess availability of the applicable facility for the most recent fiscal quarter.

In addition to paying interest on outstanding principal amounts under the Senior Secured Credit Facilities, the borrowers will be required to pay a commitment fee in respect of the unutilized commitments at an annual rate of 0.375%.

The Senior Secured Credit Facilities contain a financial covenant that if either (a) excess availability is less than the greater of (i) 12.5% of the lesser of the commitments and the borrowing base and (ii) $31,250,000 or (b) U.S. availability is less than the greater of (i) 12.5% of the lesser of the U.S. commitments and U.S. borrowing base and (ii) $18,750,000, then following such event, Kraton and its restricted subsidiaries must maintain a fixed charge coverage ratio of at least 1.0 to 1.0 for four fiscal quarters (or for a shorter

16


 

duration if certain financial conditions are met). The Senior Secured Credit Facilities contain certain customary events of default, including, without limitation, a failure to make payments under the facility, cross-default and cross-judgment default, certain bankruptcy events and certain change of control events.

As of March 31, 2014, our available borrowing capacity was $213.3 million of which $0.0 million was drawn. As of the date of this filing, our available borrowing capacity was $227.8 million, of which $0.0 million was drawn.

6.75% Senior Notes due 2019. Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019 pursuant to an indenture, dated February 11, 2011 ($250.0 million senior notes) and supplemental indenture thereto dated March 20, 2012 ($100.0 million senior notes). The indenture provides that the notes are general unsecured, senior obligations and will be unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year.

Capital Lease. In January 2014, we entered into a 10 year capital lease for a portion of the boiler MACT capital investment with a principal amount of $7.0 million. 

Debt Maturities. The remaining principal payments on our outstanding total debt as of March 31, 2014, are as follows:

 

 

Principal Payments

 

 

(In thousands)

 

March 31:

 

 

 

2015

$

2,996

 

2016

 

89

 

2017

 

94

 

2018

 

100

 

Thereafter

 

350,743

 

Total debt

$

354,022

 

 

See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for fair value information related to our long-term debt.

 

7. Debt Issuance Costs

We capitalize the debt issuance costs related to issuing long-term debt and amortize these costs using the effective interest method, except for costs related to revolving debt, which are amortized using the straight-line method. Amortization of debt issue costs and the accelerated write-off of debt issue costs in connection with refinancing activities are recorded as a component of interest expense. We had net debt issuance costs of $10.9 million and $11.4 million (of which $2.2 million and $2.2 million were included in other current assets) as of March 31, 2014 and December 31, 2013, respectively. In connection with the March 2013 refinancing of our indebtedness, we charged to interest expense $5.0 million of unamortized debt issuance costs related to our previously existing indebtedness and we capitalized $4.8 million of debt issuance costs related to our new indebtedness. We amortized $0.6 million and $0.8 million, (which excludes the $5.0 million of accelerated amortization) of debt issuance costs for the three months ended March 31, 2014 and 2013, respectively.    

 

8. Fair Value Measurements, Financial Instruments and Credit Risk

ASC 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 requires entities to, among other things, maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

17


 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions.

In accordance with ASC 820, these two types of inputs have created the following fair value hierarchy:

·

Level 1—Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets;

·

Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

·

Quoted prices for similar assets or liabilities in active markets

·

Quoted prices for identical or similar assets or liabilities in markets that are not active

·

Inputs other than quoted prices that are observable for the asset or liability

·

Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

·

Level 3—Inputs that are unobservable and reflect our assumptions used in pricing the asset or liability based on the best information available under the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

Recurring Fair Value Measurements. The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2014 and December 31, 2013. These financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment, which judgment may affect the valuation of their fair value and their placement within the fair value hierarchy levels.

 

 

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

Balance Sheet Location

 

March 31, 2014

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

 

 

(In thousands)

 

Retirement plan asset-noncurrent

Other long-term assets

 

$

1,980

 

 

$

1,980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

Balance Sheet Location

 

December 31, 2013

 

 

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

 

 

(In thousands)

 

Retirement plan asset-noncurrent

Other long-term assets

 

$

1,908

 

 

$

1,908

 

 

 

 

 

 

 

 

18


 

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. We seek to minimize this risk by limiting our counterparties to major financial institutions with acceptable credit ratings and by monitoring the total value of positions with individual counterparties. In the event of a default by one of our counterparties, we may not receive payments provided for under the terms of our derivatives.

The following table presents the carrying values and approximate fair values of our long-term debt.

 

 

 

March 31, 2014

 

 

December 31, 2013

 

 

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

 

 

(In thousands)

 

 

(In thousands)

 

6.75% unsecured notes (quoted prices in active market for identical assets - level 1)

 

$

350,949

 

 

$

371,875

 

 

$

350,989

 

 

$

369,250

 

Capital lease obligation (significant unobservable inputs - level 2)

 

$

4,022

 

 

$

4,022

 

 

$

 

 

$

 

 

Financial Instruments    

Interest Rate Swap Agreements. Periodically, we enter into interest rate swap agreements to hedge or otherwise protect against interest rate fluctuations on a portion of our variable rate debt. These interest rate swap agreements are designated as cash flow hedges on our exposure to the variability of future cash flows. In June 2011, we entered into a $75.0 million notional amount interest rate swap agreement with respect to a portion of our outstanding term loans. This agreement was effective on July 15, 2011 and was set to expire on June 15, 2014. However, on March 27, 2013, in connection with the refinancing of our credit facility, we terminated and settled the interest rate swap agreement, and as a result, recognized $0.7 million of interest expense for the three months ended March 31, 2013.

Fair Value Hedges. In April 2012, we entered into a series of non-deliverable forward contracts to reduce our exposure to fluctuations in the Canadian dollar (“CAD”) against the U.S. dollar associated with the funding of certain capital expenditures. The non-deliverable forward contracts outstanding as of March 31, 2013, had notional amounts of CAD $2.5 million and CAD $1.6 million with settlement dates of July 11, 2013 and August 1, 2013, respectively. Due to an adjustment in the underlying payment schedule, in March 2013, we settled the hedge with a notional amount of CAD $2.5 million with a settlement date of July 11, 2013 and entered into a new hedge with a notional value of CAD $2.5 million with a settlement date of September 9, 2013. We also settled the hedge with the notional value of CAD $1.6 million with a settlement date of August 1, 2013 and entered into a new hedge with a notional value of CAD $1.6 million and a settlement date of October 8, 2013. The ineffective portion of the settlement of theses hedges was immaterial. These non-deliverable forward contracts qualified for hedge accounting and were designated as fair value hedges in accordance with ASC 815-25 “Fair Value Hedges.” For the effective portion of these hedges, we recorded an aggregate $0.1 million gain, which offset the $0.1 million loss on the exposure to the CAD for the three months ended March 31, 2013.

Net Investment Hedges. During 2012, we entered into a series of non-deliverable forward and foreign currency option contracts to protect our net investment in our European subsidiaries against adverse changes in exchange rates by fixing the U.S. dollar/Euro exchange rate. The notional amounts of these contracts ranged from €50.0 million to €100.0 million with all contracts expiring after thirty days. These contracts qualify for hedge accounting and were designated as net investment hedges in accordance with ASC 815-35 “Net Investment Hedges.” We recorded an aggregate $0.2 million loss in accumulated other comprehensive loss related to the settlement of the effective portion of the contracts during the three months ended March 31, 2013.

Foreign Currency Hedges. Periodically, we enter into foreign currency agreements to hedge or otherwise protect against fluctuations in foreign currency exchange rates. These agreements typically do not qualify for hedge accounting and gains/losses resulting from both the up-front premiums and/or settlement of the hedges at expiration of the agreements are recognized in the period in which they are incurred. The contracts are structured such that the underlying foreign currency exchange gains/losses would be offset by the mark-to-market impact of the hedging instruments and reduce the impact of foreign currency exchange movements throughout the period. These contracts did not qualify for hedge accounting. For the three months ended March 31, 2014 and 2013, we settled these hedges and recorded a loss of $0.2 million and a loss of $1.7 million, respectively. In all periods, the losses on settlement of these hedges offset the underlying foreign currency exchange gains recorded in cost of goods sold.

19


 

Credit Risk

We analyze our counterparties’ financial condition prior to extending credit and we establish credit limits and monitor the appropriateness of those limits on an ongoing basis. We also obtain cash, letters of credit or other acceptable forms of security from customers to provide credit support, where appropriate, based on our financial analysis of the customer and the contractual terms and conditions applicable to each transaction.

 

9. Income Taxes

 

Our income tax expense was $0.1 million and $1.4 million for the three months ended March 31, 2014 and 2013, respectively. Our effective tax rate was (1.5)% and (60.8)% for the three months ended March 31, 2014 and 2013, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and the change in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. As of March 31, 2014 and December 31, 2013, a valuation allowance of $90.5 million and $90.0 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We increased our valuation allowance by $0.5 million for the three months ended March 31, 2014, primarily due to current period net operating losses. We increased our valuation allowance by $7.4 million for the three months ended March 31, 2013, of which $7.6 million represents current period net operating losses, partially offset by $0.2 million which represents changes in other comprehensive income (loss). Excluding the change in our valuation allowance, our effective tax rate would have been 4.2% and 259.4% benefit for the three months ended March 31, 2014 and 2013, respectively.

As of March 31, 2014 and December 31, 2013, we had total unrecognized tax benefits of $6.7 million and $6.4 million, respectively, related to uncertain foreign tax positions, all of which, if recognized, would impact our effective tax rate. During the three months ended March 31, 2014 and 2013, we had an increase in uncertain tax positions of $0.3 million and $0.5 million, respectively, primarily related to uncertain tax positions in Europe. We recorded interest and penalties related to unrecognized tax benefits within the provision for income taxes. We believe that no current tax positions that have resulted in unrecognized tax benefits will significantly increase or decrease within one year.

We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. For our U.S. federal income tax returns, the statute of limitations has expired through the tax year ended December 31, 2003. As a result of net operating loss carryforwards from 2004, the statute of limitations remains open for all years subsequent to 2003. In addition, open tax years for state and foreign jurisdictions remain subject to examination.

      

    

 

10. Commitments and Contingencies

Legal Proceedings. We received notice from the tax authorities in Brazil assessing R$5.9 million (approximately $2.6 million converted at the March 31, 2014 exchange rate) in connection with tax credits that were generated from the purchase of certain goods which were subsequently applied by us against taxes owed. We have appealed the assertion by the tax authorities in Brazil that the goods purchased were not eligible to earn the credits. While the outcome of this proceeding cannot be predicted with certainty, we do not expect this matter to have a material adverse effect upon our financial position, results of operations or cash flows.

We and certain of our subsidiaries, from time to time, are parties to various other legal proceedings, claims and disputes that have arisen in the ordinary course of business. These claims may involve significant amounts, some of which would not be covered by insurance. A substantial settlement payment or judgment in excess of our accruals could have a material adverse effect on our financial position, results of operations or cash flows. While the outcome of these proceedings cannot be predicted with certainty, our management does not expect any of these existing matters, individually or in the aggregate, to have a material adverse effect upon our financial position, results of operations or cash flows.

20


 

Asset Retirement Obligations.

The changes in the aggregate carrying amount of our ARO liability are as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Beginning balance

$

10,497

 

 

$

9,837

 

Accretion expense

 

136

 

 

 

120

 

Obligations settled

 

(45

)

 

 

 

Foreign currency translation, net

 

3

 

 

 

(118

)

Ending Balance

$

10,591

 

 

$

9,839

 

 

Production downtime. In the first quarter of 2014 we experienced weather-related downtime at our Belpre, Ohio facility. In addition, our facility in Berre, France experienced an operating disruption resulting from a small fire which impacted one of the production lines at this facility. We incurred $13.0 million of costs in the three months ended March 31, 2104 associated with these two events, of which $3.7 million is included in other payables and accruals at March 31, 2014 based on management’s estimates of the remaining costs to be incurred.

There have been no other material changes to our Commitments and Contingencies disclosed in our most recently filed Annual Report on Form 10-K.

 

11. Employee Benefits

Retirement Plans.

The components of net periodic benefit cost related to U.S. pension benefits are as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Service cost

$

753

 

 

$

938

 

Interest cost

 

1,510

 

 

 

1,410

 

Expected return on plan assets

 

(1,915

)

 

 

(1,655

)

Amortization of prior service cost

 

430

 

 

 

1,007

 

Net periodic benefit cost

$

778

 

 

$

1,700

 

 

We made contributions of $1.4 million and $1.2 million to our pension plan in the three months ended March 31, 2014 and 2013, respectively.

The components of net periodic benefit cost related to other post-retirement benefits are as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Service cost

$

125

 

 

$

145

 

Interest cost

 

320

 

 

 

292

 

Amortization of prior service cost

 

113

 

 

 

183

 

Net periodic benefit cost

$

558

 

 

$

620

 

 

 

 

21


 

12. Industry Segment and Foreign Operations

We operate in one segment for the manufacturing and marketing of engineered polymers. In accordance with the provisions of ASC 280, “Segment Reporting,” our chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Since we operate in one segment and in one group of similar products, all financial segment and product line information required by ASC 280 can be found in the condensed consolidated financial statements.

We manufacture our products along the following primary product lines based upon polymer chemistry and process technologies:

un-hydrogenated SBCs (“USBCs”);

hydrogenated SBCs (“HSBCs”);

Cariflex™ isoprene rubber and isoprene rubber latex; and

compounds.

Sales revenue for our product lines is as follows: 

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

USBCs

$

165,521

 

 

$

196,773

 

HSBCs

 

103,777

 

 

 

108,094

 

Cariflex

 

35,363

 

 

 

27,029

 

Compounds

 

6,900

 

 

 

7,904

 

Other

 

95

 

 

 

307

 

 

$

311,656

 

 

$

340,107

 

For geographic reporting, sales revenue is attributed to the geographic location in which the customers’ facilities are located. Long-lived assets consist primarily of property, plant and equipment, which are attributed to the geographic location in which they are located and are presented at historical cost.

22


 

Sales revenue and long-lived assets by geographic region are as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Sales revenue:

 

 

 

 

 

 

 

United States

$

101,662

 

 

$

113,308

 

Germany

 

40,641

 

 

 

43,381

 

China

 

18,992

 

 

 

18,690

 

Japan

 

17,681

 

 

 

17,051

 

Thailand

 

16,248

 

 

 

9,982

 

Brazil

 

14,143

 

 

 

13,897

 

France

 

12,479

 

 

 

11,834

 

Italy

 

10,221

 

 

 

12,471

 

Belgium

 

8,186

 

 

 

10,682

 

United Kingdom

 

8,152

 

 

 

10,474

 

Netherlands

 

7,027

 

 

 

9,637

 

Malaysia

 

6,482

 

 

 

5,753

 

Taiwan

 

4,567

 

 

 

6,446

 

Sweden

 

4,425

 

 

 

4,073

 

Argentina

 

4,190

 

 

 

4,665

 

Canada

 

4,033

 

 

 

4,760

 

Mexico

 

3,747

 

 

 

4,874

 

Turkey

 

3,307

 

 

 

5,676

 

South Korea

 

2,941

 

 

 

3,223

 

Austria

 

2,815

 

 

 

1,726

 

All other countries

 

19,717

 

 

 

27,504

 

 

$

311,656

 

 

$

340,107

 

 

 

 

March 31,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Long-lived assets, at cost:

 

 

 

 

 

 

 

United States

$

464,664

 

 

$

453,157

 

France

 

124,300

 

 

 

123,804

 

Brazil

 

79,372

 

 

 

76,524

 

Germany

 

64,556

 

 

 

64,258

 

Netherlands

 

28,563

 

 

 

27,865

 

Taiwan

 

30,458

 

 

 

12,935

 

China

 

7,175

 

 

 

7,226

 

Japan

 

1,733

 

 

 

1,696

 

All other countries

 

219

 

 

 

220

 

 

$

801,040

 

 

$

767,685

 

 

 

 

 

23


 

13. Related Party Transactions

We own a 50% equity investment in a SBC manufacturing joint venture with JSR Corporation (“JSR”) under the name of Kraton JSR Elastomers K.K. (“KJE”) located in Kashima, Japan. We and JSR separately, but with equal rights, participate in distributions in the sales of the thermoplastic rubber produced by KJE.

The aggregate amounts of related-party transactions were as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Purchases from related party

$

13,787

 

 

$

12,671

 

 

Our due to related party is solely related to our commercial arrangement associated with KJE, which requires payment by each party within 150 days of invoice.

 

14. Variable Interest Entity

The following table summarizes the carrying amounts of assets and liabilities as of March 31, 2014 and December 31, 2013 for Kraton Formosa Polymers Corporation, our 50/50 joint venture with Formosa Petrochemical Corporation, before intercompany eliminations.

 

 

March 31,

 

 

December 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Cash and cash equivalents

 

54,690

 

 

 

66,816

 

Other current assets

 

386

 

 

 

256

 

Property, plant and equipment

 

30,425

 

 

 

12,912

 

Intangible assets

 

9,948

 

 

 

10,094

 

Other long-term assets

 

574

 

 

 

462

 

Total assets

$

96,023

 

 

$

90,540

 

Current liabilities

 

15,940

 

 

 

8,724

 

Total liabilities

$

15,940

 

 

$

8,724

 

 

 

 

15. Supplemental Guarantor Information

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, (“the Issuers”), are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Performance Polymers, Inc. and Elastomers Holdings LLC, a U.S. holding company and wholly-owned subsidiary of Kraton Polymers LLC, collectively, (“the Guarantors”), fully and unconditionally guarantee on a joint and several basis, the Issuers’ obligations under the 6.75% senior notes. Our remaining subsidiaries are not guarantors of the 6.75% senior notes. We do not believe that separate financial statements and other disclosures concerning the guarantor subsidiaries would provide any additional information that would be material to investors in making an investment decision.

 

 

24


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

March 31, 2014

(Unaudited)

(In thousands, except par value)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

 

 

$

6

 

 

$

936

 

 

$

96,377

 

 

$

 

 

$

97,319

 

Receivables, net of allowances of $402

 

 

 

 

380

 

 

 

56,467

 

 

 

94,001

 

 

 

 

 

 

150,848

 

Inventories of products

 

 

 

 

13

 

 

 

192,991

 

 

 

150,507

 

 

 

 

 

 

343,511

 

Inventories of materials and supplies

 

 

 

 

 

 

 

9,128

 

 

 

2,133

 

 

 

 

 

 

11,261

 

Deferred income taxes

 

 

 

 

 

 

 

3,953

 

 

 

5,811

 

 

 

 

 

 

9,764

 

Other current assets

 

 

 

 

4,103

 

 

 

772

 

 

 

15,359

 

 

 

 

 

 

20,234

 

Total current assets

 

 

 

 

4,502

 

 

 

264,247

 

 

 

364,188

 

 

 

 

 

 

632,937

 

Property, plant and equipment, less accumulated depreciation of $367,223

 

 

 

 

53,378

 

 

 

237,729

 

 

 

142,710

 

 

 

 

 

 

433,817

 

Intangible assets, less accumulated amortization of $81,489

 

 

 

 

51,080

 

 

 

4,616

 

 

 

0

 

 

 

 

 

 

55,696

 

Investment in consolidated subsidiaries

 

530,553

 

 

 

1,319,720

 

 

 

 

 

 

 

 

 

(1,850,273

)

 

 

 

Investment in unconsolidated joint venture

 

 

 

 

813

 

 

 

 

 

 

12,908

 

 

 

 

 

 

13,721

 

Debt issuance costs

 

 

 

 

5,675

 

 

 

1,730

 

 

 

1,237

 

 

 

 

 

 

8,642

 

Deferred income taxes

 

 

 

 

510

 

 

 

 

 

 

942

 

 

 

 

 

 

1,452

 

Other long-term assets

 

 

 

 

189

 

 

 

542,403

 

 

 

74,588

 

 

 

(591,442

)

 

 

25,738

 

Total assets

$

530,553

 

 

$

1,435,867

 

 

$

1,050,725

 

 

$

596,573

 

 

$

(2,441,715

)

 

$

1,172,003

 

LIABILITIES AND STOCKHOLDERS' AND

   MEMBER'S EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current portion of long-term debt

$

 

 

$

 

 

$

2,996

 

 

$

 

 

$

 

 

$

2,996

 

Accounts payable-trade

 

 

 

 

1,875

 

 

 

33,050

 

 

 

66,394

 

 

 

 

 

 

101,319

 

Other payables and accruals

 

 

 

 

15,703

 

 

 

12,439

 

 

 

15,114

 

 

 

 

 

 

43,256

 

Deferred income taxes

 

 

 

 

 

 

 

 

 

 

183

 

 

 

 

 

 

183

 

Due to related party

 

 

 

 

 

 

 

 

 

 

26,295

 

 

 

 

 

 

26,295

 

Total current liabilities

 

 

 

 

17,578

 

 

 

48,485

 

 

 

107,986

 

 

 

 

 

 

174,049

 

Long-term debt, net of current portion

 

 

 

 

350,949

 

 

 

1,026

 

 

 

 

 

 

 

 

 

351,975

 

Deferred income taxes

 

 

 

 

10,032

 

 

 

3,952

 

 

 

4,248

 

 

 

 

 

 

18,232

 

Other long-term liabilities

 

 

 

 

527,564

 

 

 

64,516

 

 

 

75,967

 

 

 

(591,442

)

 

 

76,605

 

Total liabilities

 

 

 

 

906,123

 

 

 

117,979

 

 

 

188,201

 

 

 

(591,442

)

 

 

620,861

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' and member's equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; non issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized; 32,774 shares issued and outstanding

 

328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

328

 

Additional paid in capital

 

367,307

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

367,307

 

Member's equity

 

 

 

 

530,553

 

 

 

968,721

 

 

 

350,999

 

 

 

(1,850,273

)

 

 

 

Retained earnings

 

162,918

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

162,918

 

Accumulated other comprehensive income (loss)

 

 

 

 

(809

)

 

 

(35,975

)

 

 

17,331

 

 

 

 

 

 

(19,453

)

Kraton stockholders' and member's equity

 

530,553

 

 

 

529,744

 

 

 

932,746

 

 

 

368,330

 

 

 

(1,850,273

)

 

 

511,100

 

Noncontrolling interest

 

 

 

 

 

 

 

 

 

 

40,042

 

 

 

 

 

 

40,042

 

Total stockholders' and member's equity

 

530,553

 

 

 

529,744

 

 

 

932,746

 

 

 

408,372

 

 

 

(1,850,273

)

 

 

551,142

 

Total liabilities and stockholders' and member's equity

$

530,553

 

 

$

1,435,867

 

 

$

1,050,725

 

 

$

596,573

 

 

$

(2,441,715

)

 

$

1,172,003

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

25


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2013

(In thousands, except par value)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

 

 

$

 

 

$

11,792

 

 

$

164,080

 

 

$

 

 

$

175,872

 

Receivables, net of allowances of $315

 

 

 

 

80

 

 

 

45,971

 

 

 

83,305

 

 

 

 

 

 

129,356

 

Inventories of products

 

 

 

 

 

 

 

176,823

 

 

 

151,949

 

 

 

 

 

 

328,772

 

Inventories of materials and supplies

 

 

 

 

 

 

 

8,898

 

 

 

2,049

 

 

 

 

 

 

10,947

 

Deferred income taxes

 

 

 

 

 

 

 

3,952

 

 

 

3,644

 

 

 

 

 

 

7,596

 

Other current assets

 

 

 

 

2,071

 

 

 

1,541

 

 

 

17,053

 

 

 

 

 

 

20,665

 

Total current assets

 

 

 

 

2,151

 

 

 

248,977

 

 

 

422,080

 

 

 

 

 

 

673,208

 

Property, plant and equipment, less accumulated depreciation of $353,428

 

 

 

 

47,157

 

 

 

241,650

 

 

 

125,450

 

 

 

 

 

 

414,257

 

Intangible assets, less accumulated amortization of $78,784

 

 

 

 

34,208

 

 

 

23,280

 

 

 

 

 

 

 

 

 

57,488

 

Investment in consolidated subsidiaries

 

534,742

 

 

 

1,325,811

 

 

 

 

 

 

 

 

 

(1,860,553

)

 

 

 

Investment in unconsolidated joint venture

 

 

 

 

813

 

 

 

 

 

 

13,261

 

 

 

 

 

 

14,074

 

Debt issuance costs

 

 

 

 

6,000

 

 

 

1,874

 

 

 

1,339

 

 

 

 

 

 

9,213

 

Deferred income taxes

 

 

 

 

536

 

 

 

 

 

 

790

 

 

 

 

 

 

1,326

 

Other long-term assets

 

 

 

 

612

 

 

 

563,305

 

 

 

108,393

 

 

 

(647,079

)

 

 

25,231

 

Total assets

$

534,742

 

 

$

1,417,288

 

 

$

1,079,086

 

 

$

671,313

 

 

$

(2,507,632

)

 

$

1,194,797

 

LIABILITIES AND STOCKHOLDERS' AND MEMBER'S EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable-trade

$

 

 

$

104

 

 

$

48,259

 

 

$

67,373

 

 

$

 

 

$

115,736

 

Other payables and accruals

 

 

 

 

7,875

 

 

 

25,970

 

 

 

20,694

 

 

 

 

 

 

54,539

 

Deferred income taxes

 

 

 

 

 

 

 

 

 

 

182

 

 

 

 

 

 

182

 

Due to related party

 

 

 

 

 

 

 

 

 

 

24,603

 

 

 

 

 

 

24,603

 

Total current liabilities

 

 

 

 

7,979

 

 

 

74,229

 

 

 

112,852

 

 

 

 

 

 

195,060

 

Long-term debt, net of current portion

 

 

 

 

350,989

 

 

 

 

 

 

 

 

 

 

 

 

350,989

 

Deferred income taxes

 

 

 

 

10,553

 

 

 

3,953

 

 

 

3,853

 

 

 

 

 

 

18,359

 

Other long-term liabilities

 

 

 

 

513,560

 

 

 

64,394

 

 

 

145,116

 

 

 

(647,079

)

 

 

75,991

 

Total liabilities

 

 

 

 

883,081

 

 

 

142,576

 

 

 

261,821

 

 

 

(647,079

)

 

 

640,399

 

Commitments and contingencies (note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' and member's equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000 shares authorized; non issued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 500,000 shares authorized; 32,547 shares issued and outstanding

 

325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

325

 

Additional paid in capital

 

363,590

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

363,590

 

Member's equity

 

 

 

 

534,742

 

 

 

972,485

 

 

 

353,326

 

 

 

(1,860,553

)

 

 

 

Retained earnings

 

170,827

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

170,827

 

Accumulated other comprehensive income (loss)

 

 

 

 

(535

)

 

 

(35,975

)

 

 

15,258

 

 

 

 

 

 

(21,252

)

Kraton stockholders' and member's equity

 

534,742

 

 

 

534,207

 

 

 

936,510

 

 

 

368,584

 

 

 

(1,860,553

)

 

 

513,490

 

Noncontrolling interest

 

 

 

 

 

 

 

 

 

 

40,908

 

 

 

 

 

 

40,908

 

Total stockholders' and member's equity

 

534,742

 

 

 

534,207

 

 

 

936,510

 

 

 

409,492

 

 

 

(1,860,553

)

 

 

554,398

 

Total liabilities and stockholders' and member's equity

$

534,742

 

 

$

1,417,288

 

 

$

1,079,086

 

 

$

671,313

 

 

$

(2,507,632

)

 

$

1,194,797

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

26


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended March 31, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

156,838

 

 

$

191,192

 

 

$

(36,374

)

 

$

311,656

 

Cost of goods sold

 

 

 

 

(15,114

)

 

 

127,201

 

 

 

178,870

 

 

 

(36,374

)

 

 

254,583

 

Gross profit

 

 

 

 

15,114

 

 

 

29,637

 

 

 

12,322

 

 

 

 

 

 

57,073

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

4,499

 

 

 

454

 

 

 

3,344

 

 

 

 

 

 

8,297

 

Selling, general and administrative

 

 

 

 

26,696

 

 

 

88

 

 

 

7,434

 

 

 

 

 

 

34,218

 

Depreciation and amortization

 

 

 

 

5,537

 

 

 

7,171

 

 

 

3,701

 

 

 

 

 

 

16,409

 

Total operating expenses

 

 

 

 

36,732

 

 

 

7,713

 

 

 

14,479

 

 

 

 

 

 

58,924

 

Earnings (loss) in consolidated subsidiaries

 

(8,194

)

 

 

19,185

 

 

 

 

 

 

 

 

 

(10,991

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

117

 

 

 

 

 

 

117

 

Interest expense (income), net

 

 

 

 

6,255

 

 

 

125

 

 

 

(42

)

 

 

 

 

 

6,338

 

Income (loss) before income taxes

 

(8,194

)

 

 

(8,688

)

 

 

21,799

 

 

 

(1,998

)

 

 

(10,991

)

 

 

(8,072

)

Income tax expense (benefit)

 

 

 

 

(494

)

 

 

3

 

 

 

613

 

 

 

 

 

 

122

 

Consolidated net income (loss)

 

(8,194

)

 

 

(8,194

)

 

 

21,796

 

 

 

(2,611

)

 

 

(10,991

)

 

 

(8,194

)

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(285

)

 

 

 

 

 

(285

)

Net income (loss) attributable to Kraton

$

(8,194

)

 

$

(8,194

)

 

$

21,796

 

 

$

(2,326

)

 

$

(10,991

)

 

$

(7,909

)

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

27


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended March 31, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Sales revenue

$

 

 

$

 

 

$

177,582

 

 

$

203,551

 

 

$

(41,026

)

 

$

340,107

 

Cost of goods sold

 

 

 

 

1,733

 

 

 

148,119

 

 

 

171,370

 

 

 

(41,026

)

 

 

280,196

 

Gross profit (loss)

 

 

 

 

(1,733

)

 

 

29,463

 

 

 

32,181

 

 

 

 

 

 

59,911

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

4,343

 

 

 

3,570

 

 

 

 

 

 

7,913

 

Selling, general and administrative

 

 

 

 

2

 

 

 

18,971

 

 

 

7,141

 

 

 

 

 

 

26,114

 

Depreciation and amortization

 

 

 

 

4,079

 

 

 

7,534

 

 

 

3,485

 

 

 

 

 

 

15,098

 

Total operating expenses

 

 

 

 

4,081

 

 

 

30,848

 

 

 

14,196

 

 

 

 

 

 

49,125

 

Earnings (loss) in consolidated subsidiaries

 

(3,824

)

 

 

17,786

 

 

 

 

 

 

 

 

 

(13,962

)

 

 

 

Earnings of unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

134

 

 

 

 

 

 

134

 

Interest expense (income), net

 

 

 

 

15,890

 

 

 

(3,576

)

 

 

984

 

 

 

 

 

 

13,298

 

Income (loss) before income taxes

 

(3,824

)

 

 

(3,918

)

 

 

2,191

 

 

 

17,135

 

 

 

(13,962

)

 

 

(2,378

)

Income tax expense (benefit)

 

 

 

 

(94

)

 

 

11

 

 

 

1,529

 

 

 

 

 

 

1,446

 

Consolidated net income (loss)

 

(3,824

)

 

 

(3,824

)

 

 

2,180

 

 

 

15,606

 

 

 

(13,962

)

 

 

(3,824

)

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

(76

)

 

 

 

 

 

(76

)

Net income (loss) attributable to Kraton

$

(3,824

)

 

$

(3,824

)

 

$

2,180

 

 

$

15,682

 

 

$

(13,962

)

 

$

(3,748

)

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

28


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three months ended March 31, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income (loss) attributable to Kraton

$

(8,194

)

 

$

(8,194

)

 

$

21,796

 

 

$

(2,326

)

 

$

(10,991

)

 

$

(7,909

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax of $0

 

 

 

 

(274

)

 

 

 

 

 

2,073

 

 

 

 

 

 

1,799

 

Other comprehensive income (loss), net of tax

 

 

 

 

(274

)

 

 

 

 

 

2,073

 

 

 

 

 

 

1,799

 

Comprehensive income (loss) attributable to Kraton

 

(8,194

)

 

 

(8,468

)

 

 

21,796

 

 

 

(253

)

 

 

(10,991

)

 

 

(6,110

)

Comprehensive loss attributable to noncontrolling  interest

 

 

 

 

 

 

 

 

 

 

(866

)

 

 

 

 

 

(866

)

Consolidated comprehensive income (loss)

$

(8,194

)

 

$

(8,468

)

 

$

21,796

 

 

$

(1,119

)

 

$

(10,991

)

 

$

(6,976

)

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

29


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three months ended March 31, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net income (loss) attributable to Kraton

$

(3,824

)

 

$

(3,824

)

 

$

2,180

 

 

$

15,682

 

 

$

(13,962

)

 

$

(3,748

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax of $0

 

 

 

 

(106

)

 

 

 

 

 

(9,165

)

 

 

 

 

 

(9,271

)

Unrealized gain of interest rate swap, net of tax of $0

 

 

 

 

837

 

 

 

 

 

 

 

 

 

 

 

 

837

 

Unrealized loss of net investment hedge, net of tax of $0

 

 

 

 

(225

)

 

 

 

 

 

 

 

 

 

 

 

(225

)

Other comprehensive income (loss), net of tax

 

 

 

 

506

 

 

 

 

 

 

(9,165

)

 

 

 

 

 

(8,659

)

Comprehensive income (loss) attributable to Kraton

 

(3,824

)

 

 

(3,318

)

 

 

2,180

 

 

 

6,517

 

 

 

(13,962

)

 

 

(12,407

)

Comprehensive income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

224

 

 

 

 

 

 

224

 

Consolidated comprehensive income (loss)

$

(3,824

)

 

$

(3,318

)

 

$

2,180

 

 

$

6,741

 

 

$

(13,962

)

 

$

(12,183

)

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

 

30


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Three months ended March 31, 2014

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Cash flows provided by (used in) operating activities

$

 

 

$

(2,567

)

 

$

7,997

 

 

$

(59,017

)

 

$

 

 

$

(53,587

)

Cash flows provided by (used in) investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from intercompany loans

 

 

 

 

3,100

 

 

 

 

 

 

 

 

 

(3,100

)

 

 

 

Purchase of property, plant and equipment

 

 

 

 

 

 

 

(12,313

)

 

 

(7,872

)

 

 

 

 

 

(20,185

)

Purchase of software and other intangibles

 

 

 

 

(1,062

)

 

 

 

 

 

 

 

 

 

 

 

(1,062

)

Net cash provided by (used in) investing activities

 

 

 

 

2,038

 

 

 

(12,313

)

 

 

(7,872

)

 

 

(3,100

)

 

 

(21,247

)

Cash flows provided by (used in) financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital lease payments

 

 

 

 

 

 

 

(3,011

)

 

 

 

 

 

 

 

 

(3,011

)

Purchase of treasury stock

 

(429

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(429

)

Cash contributions from member

 

 

 

 

 

 

 

(429

)

 

 

 

 

 

429

 

 

 

 

Cash distributions to member

 

(106

)

 

 

535

 

 

 

 

 

 

 

 

 

(429

)

 

 

 

Proceeds from the exercise of stock options

 

535

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

535

 

Payments on intercompany loans

 

 

 

 

 

 

 

(3,100

)

 

 

 

 

 

3,100

 

 

 

 

Net cash provided by (used in) financing activities

 

 

 

 

535

 

 

 

(6,540

)

 

 

 

 

 

3,100

 

 

 

(2,905

)

Effect of exchange rate differences on cash

 

 

 

 

 

 

 

 

 

 

(814

)

 

 

 

 

 

(814

)

Net increase (decrease) in cash and cash equivalents

 

 

 

 

6

 

 

 

(10,856

)

 

 

(67,703

)

 

 

 

 

 

(78,553

)

Cash and cash equivalents, beginning of period

 

 

 

 

 

 

 

11,792

 

 

 

164,080

 

 

 

 

 

 

175,872

 

Cash and cash equivalents, end of period

$

 

 

$

6

 

 

$

936

 

 

$

96,377

 

 

$

 

 

$

97,319

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

31


 

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Three months ended March 31, 2013

(Unaudited)

(In thousands)

 

 

Kraton

 

 

Kraton Polymers LLC (1)

 

 

Guarantor Subsidiaries

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Cash flows provided by (used in) operating activities

$

 

 

$

34,273

 

 

$

(99,572

)

 

$

44,525

 

 

$

 

 

$

(20,774

)

Cash flows provided by (used in) investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayments of intercompany loans

 

 

 

 

64,517

 

 

 

 

 

 

 

 

 

(64,517

)

 

 

 

Purchase of property, plant and equipment

 

 

 

 

 

 

 

(4,060

)

 

 

(10,395

)

 

 

 

 

 

(14,455

)

Purchase of software and other intangibles

 

 

 

 

 

 

 

(641

)

 

 

(66

)

 

 

 

 

 

(707

)

Settlement of net investment hedge

 

 

 

 

(2,225

)

 

 

 

 

 

 

 

 

 

 

 

(2,225

)

Net cash provided by (used in) investing activities

 

 

 

 

62,292

 

 

 

(4,701

)

 

 

(10,461

)

 

 

(64,517

)

 

 

(17,387

)

Cash flows provided by (used in) financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from debt

 

 

 

 

 

 

 

40,000

 

 

 

 

 

 

 

 

 

40,000

 

Repayments of debt

 

 

 

 

(96,875

)

 

 

 

 

 

 

 

 

 

 

 

(96,875

)

Capital lease payments

 

 

 

 

 

 

 

(950

)

 

 

 

 

 

 

 

 

(950

)

Cash contributions from member

 

 

 

 

310

 

 

 

 

 

 

 

 

 

(310

)

 

 

 

Cash distributions to member

 

(310

)

 

 

 

 

 

 

 

 

 

 

 

310

 

 

 

 

Contribution from noncontrolling interest

 

 

 

 

 

 

 

 

 

 

15,174

 

 

 

 

 

 

15,174

 

Proceeds from the exercise of stock options

 

310

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

310

 

Debt issuance costs

 

 

 

 

 

 

 

(1,870

)

 

 

(1,247

)

 

 

 

 

 

(3,117

)

Proceeds from (repayments of) intercompany loans

 

 

 

 

 

 

 

33,336

 

 

 

(97,853

)

 

 

64,517

 

 

 

 

Net cash provided by (used in) financing activities

 

 

 

 

(96,565

)

 

 

70,516

 

 

 

(83,926

)

 

 

64,517

 

 

 

(45,458

)

Effect of exchange rate differences on cash

 

 

 

 

 

 

 

 

 

 

(3,429

)

 

 

 

 

 

(3,429

)

Net decrease in cash and cash equivalents

 

 

 

 

 

 

 

(33,757

)

 

 

(53,291

)

 

 

 

 

 

(87,048

)

Cash and cash equivalents, beginning of period

 

 

 

 

 

 

 

80,903

 

 

 

142,263

 

 

 

 

 

 

223,166

 

Cash and cash equivalents, end of period

$

 

 

$

 

 

$

47,146

 

 

$

88,972

 

 

$

 

 

$

136,118

 

 

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

 

 

 

32


 

 

16. Subsequent Events

We have evaluated significant events and transactions that occurred after the balance sheet date and determined that there were no events or transactions other than those disclosed above that would require recognition or disclosure in our condensed consolidated financial statements for the period ended March 31, 2014.

 

 

 

33


 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

INTRODUCTION

You should read the following discussion of our financial condition and results of operations with our audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K as of and for the year ended December 31, 2013. This discussion contains forward-looking statements and involves numerous risks, assumptions and uncertainties, including, but not limited to, the risk factors discussed in the “Risk Factors” section of our most recent Form 10-K, as well as in “Factors Affecting Our Results of Operations” and elsewhere in this Form 10-Q. Actual results may differ materially from those contained in any forward-looking statements.

OVERVIEW

We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability.

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than less differentiated products. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products, such as disposable diapers, and in the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as, flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms. We believe the versatility of Cariflex provides opportunities for new, high margin applications.

We have a portfolio of innovations at various stages of development and commercialization, including

polyvinyl chloride alternatives for wire and cable, and medical applications;

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

highly-modified asphalt (“HiMA”) for high-performance paving applications;

NEXAR family of membrane polymers for water filtration, heating, ventilation, air conditioning and breathable fabrics; and

synthetic cement formulations and other oilfield applications.

Our products are manufactured along the following primary product lines based upon polymer chemistry and process technologies:

un-hydrogenated SBCs (“USBCs”);

hydrogenated SBCs (“HSBCs”);

Cariflex isoprene rubber (“IR”) and isoprene rubber latex (“IRL”); and

compounds.

 

34


 

The majority of worldwide SBC production is dedicated to USBCs, which are primarily used in paving and roofing, in adhesives, sealants and coatings, and in footwear applications. HSBCs, which are significantly more complex and capital-intensive to manufacture than USBCs, are primarily used in more differentiated applications, such as soft touch and flexible materials, personal hygiene products, medical products, automotive components, and certain adhesives and sealant applications.

 

 

Three months ended March 31,

 

Product Line Sales Revenue:

2014

 

 

2013

 

USBCs

 

53.1

%

 

 

57.9

%

HSBCs

 

33.3

%

 

 

31.8

%

Cariflex

 

11.4

%

 

 

7.9

%

Compounds

 

2.2

%

 

 

2.3

%

Other

 

0.0

%

 

 

0.1

%

 

 

Three months ended March 31,

 

End Use Markets:

2014

 

 

2013

 

Advanced Materials

 

26.5

%

 

 

28.4

%

Adhesives, Sealants and Coatings

 

39.6

%

 

 

38.7

%

Paving and Roofing

 

22.6

%

 

 

24.9

%

Cariflex

 

11.3

%

 

 

7.9

%

Other

 

0.0

%

 

 

0.1

%

2014 First Quarter Financial Overview

Sales volume was 74.4 kilotons in the first quarter of 2014 compared to 78.2 kilotons in the first quarter of 2013.

Sales revenue was $311.7 million in the first quarter of 2014 compared to $340.1 million in the first quarter of 2013.

Gross profit was $57.1 million in the first quarter of 2014 compared to $59.9 million in the first quarter of 2013. Gross profit at estimated current replacement cost (“ECRC”) was $53.0 million in the first quarter of 2014 compared to $60.4 million in the first quarter of 2013.

Adjusted EBITDA was $41.5 million in the first quarter of 2014 compared to $28.7 million in the first quarter of 2013. Adjusted EBITDA at ECRC was $37.5 million in the first quarter of 2014 compared to $29.2 million in the first quarter of 2013.

Net loss attributable to Kraton was $(7.9) million or $(0.24) per diluted share in the first quarter of 2014 compared to net loss of $(3.7) million or $(0.12) per diluted share in the first quarter of 2013. Diluted loss per share was impacted by items that are discussed further in Net loss attributable to Kraton.

RESULTS OF OPERATIONS

Factors Affecting Our Results of Operations

Raw Materials and Product Mix. Our results of operations are directly affected by the cost of raw materials. We use butadiene, styrene and isoprene as our primary raw materials in manufacturing our products. On a FIFO basis, these monomers together represented approximately $128.0 million and $162.3 million or 50.3% and 57.9% of our total cost of goods sold for the three months ended March 31, 2014 and 2013, respectively. Since the cost of our three primary raw materials comprise a significant amount of our total cost of goods sold, our selling prices for our products and therefore our total sales revenue are impacted by movements in our raw material costs, as well as the cost of other inputs. In addition, product mix can have an impact on our overall unit selling prices because we provide an extensive product offering and therefore experience a wide range of unit selling prices.

The cost of these monomers has generally correlated with changes in energy prices, supply and demand factors, and prices for natural and synthetic rubber. Average purchase prices for each of these monomers decreased during the three months ended March 31, 2014 compared to the three months ended March 31, 2013.

35


 

We use the first-in, first-out (FIFO) basis of accounting for inventory and cost of goods sold and therefore gross profit. In periods of raw material price volatility, reported results under FIFO will differ from what the results would have been if cost of goods sold were based on ECRC. Specifically, in periods of rising raw material costs, reported gross profit will be higher under FIFO than under ECRC. Conversely, in periods of declining raw material costs, reported gross profit will be lower under FIFO than under ECRC. In recognition of the fact that the cost of raw materials affects our results of operations and the comparability of our results of operations we provide the spread between FIFO and ECRC.

In the three months ended March 31, 2014, reported results under FIFO were higher than results would have been on an ECRC basis by $4.0 million; and

In the three months ended March 31, 2013, reported results under FIFO were lower than results would have been on an ECRC basis by $0.5 million.

International Operations and Currency Fluctuations. We operate a geographically diverse business, serving customers in over 60 countries from five manufacturing facilities on four continents. Although we sell and manufacture our products in many countries, our sales and production costs are mainly denominated in U.S. dollars, Euro, Japanese Yen and Brazilian Real. From time to time, we use hedging strategies to reduce our exposure to currency fluctuations.

We generated our sales revenue from customers located in the following regions.

 

 

Three months ended

March 31,

 

Revenue by Geography:

2014

 

 

2013

 

Americas

 

41.2

%

 

 

41.9

%

Europe, Middle East and Africa

 

35.4

%

 

 

37.2

%

Asia Pacific

 

23.4

%

 

 

20.9

%

Our financial results are subject to gains and losses on currency translations, which occur when the financial statements of our foreign operations are translated into U.S. dollars. The financial statements of operations outside the United States where the local currency is considered to be the functional currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and the average exchange rate for each period for revenues, expenses, gains and losses and cash flows. The effect of translating the balance sheet into U.S. dollars is included as a component of accumulated other comprehensive income (loss). Any appreciation of the functional currencies against the U.S. dollar will increase the U.S. dollar equivalent of amounts of revenues, expenses, gains and losses and cash flows, and any depreciation of the functional currencies will decrease the U.S. dollar amounts reported. Our results of operations are also subject to currency transaction risk. We incur currency transaction risk when we enter into either a purchase or sale transaction using a currency other than the local currency of the transacting entity. The estimated impact from currency fluctuations amounted to pre-tax losses of $1.4 million and $1.0 million for the three months ended March 31, 2014 and 2013, respectively. The primary driver for the increase in our pre-tax losses was the change in foreign currency exchange rates between the Brazilian Real and U.S. dollar and the Japanese Yen and U.S. dollar, for the three months ended March 31, 2014 and 2013, respectively.

Seasonality. Seasonal changes and weather conditions typically affect the Paving and Roofing end use market and generally result in higher sales volumes into this end use market in the second and third quarters of the calendar year compared to the first and fourth quarters of the calendar year. Our other end use markets tend to show relatively little seasonality.

Recent Developments

Combination with SBC Business of LCY

As previously announced, on January 28, 2014, we and two wholly-owned subsidiaries entered into a definitive agreement with LCY and a wholly-owned subsidiary of LCY (together with LCY, the “LCY Parties”) to combine with the SBC business of LCY. LCY’s SBC business operates through facilities located in Taiwan, Huizhou, China and Baytown, Texas. LCY will remain as a separate company following the combination and continue to operate its other lines of business following the closing.

36


 

Prior to the execution of the combination agreement, we formed a new holding company organized under the laws of England (“UK Holdco”). Pursuant to a merger contemplated in the combination agreement, each outstanding share of common stock of our company will be converted into the right to receive one ordinary share of UK Holdco, and we will become a wholly-owned subsidiary of UK Holdco. In addition, UK Holdco will issue ordinary shares to the LCY Parties in exchange for LCY’s SBC business, which will be contributed to UK Holdco through the contribution of the equity interests in a group of LCY’s subsidiaries (the “LCY Combination”).

The shares to be issued to LCY at closing will constitute 50% of the shares of UK Holdco that will be outstanding immediately after the closing of the transactions contemplated by the combination agreement. The other 50% of the shares of UK Holdco will be owned by the stockholders of our company immediately prior to such closing. UK Holdco and LCY have also agreed to enter into a shareholder agreement (the “Shareholder Agreement”) at the closing of the transactions. The Shareholder Agreement will set forth certain rights and limitations relating to LCY’s ownership of the UK Holdco shares, including provisions relating to, among other things, representation on UK Holdco’s board of directors (“UK Holdco Board”), standstill restrictions on certain actions (including the acquisition by LCY of additional UK Holdco shares), UK Holdco Board approval requirements on certain significant actions by UK Holdco, preemptive rights for LCY to purchase additional UK Holdco shares, restrictions on the direct or indirect transfer of the UK Holdco shares to be owned by LCY, arrangements regarding the voting of the UK Holdco shares held by LCY, restrictions on competition with UK Holdco on the part of LCY and registration rights for the UK Holdco shares to be held by LCY.

The closing of the transactions is subject to approval by the stockholders of our company, receipt of certain regulatory approvals and other conditions. The stockholders of LCY approved the transactions pursuant to a stockholder vote held on March 31, 2014. Closing of the transactions is expected to occur in the fourth quarter of 2014. Upon and after closing, the name of UK Holdco will be Kraton Performance Polymers plc, and the shares will be listed on the NYSE.

After the closing of the transactions, the UK Holdco Board will consist of fourteen directors, consisting of seven LCY-designated directors and seven directors that currently serve on our board of directors. Our chairman of the board of directors, Dan Smith, will be the initial chairman of the UK Holdco Board upon the closing, and it is anticipated he will serve in that position for two years following the closing. The chairman for the next two years will be selected by the LCY designees on the UK Holdco Board, and thereafter the chairman will be selected by the full UK Holdco Board. Kevin M. Fogarty, our current chief executive officer, will serve as chief executive officer of UK Holdco upon the closing. See “Part I, Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 for a discussion of certain risks and uncertainties relating to the LCY Combination.

Production downtime. In the first quarter of 2014 we experienced weather-related downtime at our Belpre, Ohio facility. In addition, our facility in Berre, France experienced an operating disruption resulting from a small fire which impacted one of the production lines at this facility. We have incurred $13.0 million of costs resulting from these events in the three months ended March 31, 2014.

Outlook

We currently estimate that our results in the second quarter of 2014 will reflect a positive spread between FIFO and ECRC of approximately $6.0 million.

37


 

Three Months Ended March 31, 2014 Compared to Three Months Ended March 31, 2013

Sales Revenue

Sales revenue was $311.7 million on sales volumes of 74.4 kilotons for the three months ended March 31, 2014 compared to $340.1 million on sales volumes of 78.2 kilotons for the three months ended March 31, 2013. Sales revenue declined $28.5 million or 8.4% compared to the first quarter 2013, with $18.8 million of the decrease attributable to a reduction in global product sales prices associated with lower average raw material costs and $9.4 million resulting from lower sales volumes.

With respect to sales revenue in each of our end use markets:

Advanced Materials sales revenue was $82.7 million for the three months ended March 31, 2014 compared to $96.6 million for the three months ended March 31, 2013. The $13.9 million or 14.4% revenue decline (a decline of $14.4 million or 14.9% excluding a $0.5 million positive effect from currency fluctuations) was due to a 9.4% decline in sales volumes and, to a lesser extent, lower average selling prices reflective of lower raw material costs, primarily butadiene.  The sales volume decline was primarily due to lower volume in consumer and personal care applications. However, innovation sales volumes were up, reflecting a trend Kraton has experienced over the past year of increasing demand for innovative USBC-based solutions as an alternative for HSBC-based solutions for certain personal care applications.

Adhesives, Sealants and Coatings sales revenue was $123.3 million for the three months ended March 31, 2014 compared to $131.5 million for the three months ended March 31, 2013. The $8.2 million or 6.3% revenue decline (a decline of $7.4 million or 5.7% excluding a $0.8 million negative effect from currency fluctuations) was due to a 3.2% decline in sales volumes and lower average selling prices, reflective of lower raw material costs. The decline in volume was primarily due to lower sales into industrial and pressure sensitive adhesive applications, the latter in part, reflecting the impact of production outages during the first quarter of 2014 at the Belpre facility. These declines were partially offset by increased sales into lubricant additive applications.

Paving and Roofing sales revenue was $70.3 million for the three months ended March 31, 2014 compared to $84.7 million for the three months ended March 31, 2013. The $14.4 million or 17.0% revenue decline (a decline of $14.6 million or 17.2% excluding a $0.2 million positive effect from currency fluctuations) was due to an 8.0% decline in sales volumes and lower average selling prices reflective of lower raw material costs, primarily butadiene. Growth in European roofing applications partially offset volume declines in paving applications, principally in Europe, and to a lesser extent, North America. These declines were partially attributable to the production outages in the quarter.

CariflexTM sales revenue was $35.4 million for the three months ended March 31, 2014 compared to $27.0 million for the three months ended March 31, 2013. The $8.3 million or 30.8% revenue increase was primarily due to a 35.6% increase in sales volumes, mainly in the surgical glove market and other medical and innovation applications.

Cost of Goods Sold

Cost of goods sold was $254.6 million for the three months ended March 31, 2014 compared to $280.2 million for the three months ended March 31, 2013. The $25.6 million or 9.1% decrease was driven largely by a $26.4 million reduction in raw material costs, partially offset by higher costs including $12.4 million associated with the weather-related production downtime at our Belpre, Ohio facility and an operating disruption from a small fire at our Berre, France facility in the first quarter of 2014.

Gross Profit

Gross profit was $57.1 million for the three months ended March 31, 2014 compared to $59.9 million for the three months ended March 31, 2013, a decrease of $2.8 million or 4.7%. Gross profit as a percentage of sales revenue was 18.3% and 17.6% for the three months ended March 31, 2014 and 2013, respectively. Gross profit includes the $12.4 million negative impact associated with the production downtime. Lower cost of raw materials aggregating $26.4 million more than offset the $18.8 million reduction in global selling prices. Adjusting for the $4.0 million positive spread between FIFO and ECRC in the first quarter 2014 and the negative spread of $0.5 million in the first quarter 2013, gross profit at ECRC was $53.0 million in the first quarter 2014 compared to $60.4 million in the first quarter 2013.

38


 

Operating Expenses

Research and Development. Research and development expenses were $8.3 million for the three months ended March 31, 2014 compared to $7.9 million for the three months ended March 31, 2013, an increase of $0.4 million or 4.9% primarily due to an increase in employee related costs. Research and development expenses were 2.7% and 2.3% of sales revenue for the three months ended March 31, 2014 and 2013, respectively.

Selling, General and Administrative. Selling, general and administrative expenses were $34.2 million for the three months ended March 31, 2014 compared to $26.1 million for the three months ended March 31, 2013, an increase of $8.1 million or 31.0% primarily due to $9.2 million of professional fees and other costs related to the proposed combination with the SBC Business of LCY and $0.6 million in costs related to production downtime at our Belpre, Ohio facility, partially offset by a $1.7 million decrease in other costs, primarily employee related costs. Selling, general and administrative expenses were 11.0% and 7.7% of sales revenue for the three months ended March 31, 2014 and 2013, respectively.

Depreciation and Amortization. Depreciation and amortization was $16.4 million for the three months ended March 31, 2014 compared to $15.1 million for the three months ended March 31, 2013, an increase of $1.3 million or 8.7%.

Interest expense, net

Interest expense, net was $6.3 million for the three months ended March 31, 2014 compared to $13.3 million for the three months ended March 31, 2013, a decrease of $7.0 million or 52.3%. The decrease was due to charges aggregating $5.7 million incurred in connection with our March 2013 refinancing and lower outstanding indebtedness.

Income tax expense

Our income tax expense was $0.1 million and $1.4 million for the three months ended March 31, 2014 and 2013, respectively.  Our effective tax rate was (1.5)% and (60.8)% for the three months ended March 31, 2014 and 2013, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and changes in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion, or all, of our deferred tax assets will not be realized. As of March 31, 2014 and December 31, 2013, a valuation allowance of $90.5 million and $90.0 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We increased our valuation allowance by $0.5 million for the three months ended March 31, 2014, primarily due to current period net operating losses. We increased our valuation allowance by $7.4 million for the three months ended March 31, 2013, of which $7.6 million represents current period net operating losses, partially offset by $0.2 million which represents changes in other comprehensive income (loss). Excluding the change in our valuation allowance, our effective tax rate would have been 4.2% and 259.4% benefit for the three months ended March 31, 2014 and 2013, respectively.

Net loss attributable to Kraton

Net loss attributable to Kraton was $(7.9) million or $(0.24) per diluted share for the three months ended March 31, 2014, an increase in net loss of $4.2 million compared to net loss of $(3.7) million or $(0.12) per diluted share for the three months ended March 31, 2013.

Net loss for the three months ended March 31, 2014 included the following items, net of tax:

Restructuring and other charges of $0.4 million or $0.01 per diluted share

Fees related to the proposed combination with the SBC Business of LCY of $9.2 million or $0.28 per diluted share

Production downtime at our Belpre, Ohio and Berre, France facilities of $13.0 million or $0.40 per diluted share

Start-up charges related to the joint venture with FPCC of $0.4 million or $0.01 per diluted share, partially offset by a

Positive spread between FIFO and ECRC of $4.0 million or $0.12 per diluted share

39


 

Net loss for the three months ended March 31, 2013 included the following items, net of tax:

Charges associated with the credit facility refinancing of $5.7 million or $0.18 per diluted share

Negative spread between FIFO and ECRC of $0.5 million or $0.02 per diluted share

Critical Accounting Policies

For a discussion of our critical accounting policies and estimates that require the use of significant estimates and judgments, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2013.

 

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC

We consider EBITDA, Adjusted EBITDA, Adjusted EBITDA at estimated current replacement cost (ECRC) and Gross Profit at ECRC to be important supplemental measures of our performance and believe they are frequently used by investors, securities analysts and other interested parties in the evaluation of our performance including period-to-period comparisons and/or that of other companies in our industry. In addition, management uses these measures to evaluate operating performance, and our incentive compensation plan bases incentive compensation payments on our Adjusted EBITDA at ECRC, along with other factors. EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC have limitations as analytical tools and in some cases can vary substantially from other measures of our performance. You should not consider any of them in isolation, or as substitutes for analysis of our results under U.S. generally accepted accounting principles (“GAAP”).

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

EBITDA (1)

$

14,675

 

 

$

26,018

 

Adjusted EBITDA (2)

$

41,518

 

 

$

28,677

 

Adjusted EBITDA at ECRC (3)

$

37,494

 

 

$

29,184

 

Gross Profit at ECRC (3)

$

53,049

 

 

$

60,418

 

 

 

 

(1)

EBITDA represents net income before interest, taxes, depreciation and amortization.

      

Limitations for EBITDA as an analytical tool include the following:

EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;

EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest payments, on our debt;

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and EBITDA does not reflect any cash requirements for such replacements;

EBITDA calculation under the terms of our debt agreements may vary from EBITDA presented herein, and our presentation of EBITDA herein is not for purposes of assessing compliance or non-compliance with financial covenants under our debt agreements;

other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure; and

EBITDA is not a measure of discretionary cash available to us to invest in the growth of our business.

(2)

We prepare Adjusted EBITDA by adjusting EBITDA to eliminate the impact of a number of items we do not consider indicative of our ongoing operating performance. We explain how each adjustment is derived and why we believe it is helpful and appropriate in the reconciliation below. You are encouraged to evaluate each adjustment and the reasons we consider it

40


 

appropriate for supplemental analysis. As an analytical tool, Adjusted EBITDA is subject to the limitations applicable to EBITDA described above. In addition, in evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

(3)

Adjusted EBITDA at ECRC is Adjusted EBITDA net of the impact of the spread between the FIFO basis of accounting and ECRC and Gross Profit at ECRC is gross profit net of the impact of the spread between the FIFO basis of accounting and ECRC. Although we report our financial results using the FIFO basis of accounting, as part of our pricing strategy, we measure our business performance using the estimated current replacement cost of our inventory and cost of goods sold. We maintain our perpetual inventory in our global enterprise resource planning system, where the carrying value of our inventory is determined using FIFO. At the beginning of each month, we determine the estimated current cost of our raw materials for that particular month, and using the same perpetual inventory system that we use to manage inventory and therefore costs of goods sold under FIFO, we revalue our ending inventory to reflect the total cost of such inventory as if it was valued using the estimated current replacement cost. The result of this revaluation from FIFO creates the spread between FIFO and ECRC. With inventory valued under FIFO and ECRC, we then have the ability to report cost of goods sold and therefore EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC, Gross Profit, and Gross Profit at ECRC under both our FIFO convention and under estimated current replacement cost. As an analytical tool, Adjusted EBITDA at ECRC is subject to the limitations applicable to EBITDA described above, as well as the following limitations:

due to volatility in raw material prices, Adjusted EBITDA at ECRC may, and often does, vary substantially from EBITDA, net income and other performance measures, including net income calculated in accordance with US GAAP; and

Adjusted EBITDA at ECRC may, and often will, vary significantly from EBITDA calculations under the terms of our debt agreements and should not be used for assessing compliance or non-compliance with financial covenants under our debt agreements.

Because of these and other limitations, EBITDA, Adjusted EBITDA and Adjusted EBITDA at ECRC should not be considered as a measure of discretionary cash available to us to invest in the growth of our business.

Our presentation of non-GAAP financial measures and the adjustments made therein should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, and in the future we may incur expenses or charges similar to the adjustments made in the presentation of our non-GAAP financial measures.

As a measure of our performance, Gross Profit at ECRC is limited because it often varies substantially from gross profit calculated in accordance with US GAAP due to volatility in raw material prices.

We compensate for these limitations by relying primarily on our GAAP results and using EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC only as supplemental measures. See our financial statements included elsewhere in this Form 10-Q.

We reconcile Gross Profit to Gross Profit at ECRC as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Gross profit

$

57,073

 

 

$

59,911

 

Add (deduct):

 

 

 

 

 

 

 

Spread between FIFO and ECRC

 

(4,024

)

 

 

507

 

Gross profit at ECRC

$

53,049

 

 

$

60,418

 

41


 

We reconcile consolidated net loss to EBITDA, Adjusted EBITDA and Adjusted EBITDA at ECRC as follows:

 

 

Three months ended

March 31,

 

 

2014

 

 

2013

 

 

(In thousands)

 

Net loss attributable to Kraton

$

(7,909

)

 

$

(3,748

)

Net loss attributable to noncontrolling interest

 

(285

)

 

 

(76

)

Consolidated net loss

 

(8,194

)

 

 

(3,824

)

Add:

 

 

 

 

 

 

 

Interest expense, net

 

6,338

 

 

 

13,298

 

Income tax expense

 

122

 

 

 

1,446

 

Depreciation and amortization expenses

 

16,409

 

 

 

15,098

 

EBITDA

 

14,675

 

 

 

26,018

 

Add:

 

 

 

 

 

 

 

Restructuring and other charges (a)

 

521

 

 

 

55

 

Transaction and acquisition related costs (b)

 

9,236

 

 

 

81

 

Production downtime (c)

 

13,013

 

 

 

 

Asia JV (d)

 

459

 

 

 

 

Non-cash compensation expense (e)

 

3,614

 

 

 

2,523

 

Adjusted EBITDA

 

41,518

 

 

 

28,677

 

Add (deduct):

 

 

 

 

 

 

 

Spread between FIFO and ECRC

 

(4,024

)

 

 

507

 

Adjusted EBITDA at ECRC

$

37,494

 

 

$

29,184

 

 

 

(a)

Severance expenses which are primarily recorded in cost of goods sold in 2014 and in selling, general and administrative expenses in 2013.

(b)

In 2014, primarily professional fees related to our proposed combination with the styrenic block copolymer business of LCY Chemical Corp., which are recorded in selling, general and administrative expenses.

(c)

Production downtime at our Belpre, Ohio and Berre, France facilities, of which, $12.4 million is recorded in cost of goods sold and $0.6 million is recorded in selling, general and administrative expenses.

(d)

Startup costs related to the joint venture company, Kraton Formosa Polymers Corporation, which are recorded in selling, general and administrative expenses.

(e)

For the three months ended March 31, 2014, $3.1 million is recorded in selling, general and administrative expenses, $0.3 million is recorded in research and development expenses, and $0.2 million is recorded in cost of goods sold. In 2013, all non-cash compensation expenses were recorded in selling, general and administrative expenses.  

 

LIQUIDITY AND CAPITAL RESOURCES

Known Trends and Uncertainties

Kraton Performance Polymers, Inc. is a holding company without any operations or assets other than the operations of its subsidiaries. Cash flows from operations of our subsidiaries, cash on hand and available borrowings under our credit facility are our principal sources of liquidity.

In March 2013, we entered into an asset-based revolving credit facility consisting of a U.S. senior secured revolving credit facility of $150.0 million and a Dutch senior secured revolving credit facility of $100.0 million (the “Senior Secured Credit Facilities”), to replace our then-existing senior secured credit facility, and repaid in full all outstanding amounts payable under the previously existing facility. The senior secured credit facilities are secured by receivables and inventory, and borrowing availability under the facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security. The Senior Secured Credit Facilities include a $100.0 million uncommitted accordion feature that, subject to borrowing base availability and approval of the bank syndicate, could increase aggregate availability to $350.0 million. We cannot guarantee that all of the lending counterparties contractually committed to fund a revolving credit draw request will actually fund future requests, although we

42


 

currently believe that each of the counterparties would meet their funding requirements. The Senior Secured Credit Facilities terminate on March 27, 2018; however we may, from time to time, request that the lenders extend the maturity of their commitments; provided that at no time shall there be more than four maturity dates under the Senior Secured Credit Facilities.

The Senior Secured Credit Facilities contain a financial covenant requiring us to maintain a fixed charge coverage ratio of 1.0 to 1.0 if availability under the facilities is below specified amounts. Our failure to comply with this financial maintenance covenant would give rise to a default under the Senior Secured Credit Facilities.  If factors arise that negatively impact our profitability, we may not be able to satisfy this covenant. In addition, the Senior Secured Credit Facilities contain customary events of default, including, without limitation, a failure to make payments under the facilities, cross-default with respect to other indebtedness and cross-judgment default, certain bankruptcy events and certain change of control events. If we are unable to satisfy the covenants or other provisions of the Senior Secured Credit Facilities at any future time we would need to seek an amendment or waiver of such covenants or other provisions. The respective lenders under the Senior Secured Credit Facilities may elect not to consent to any amendment or waiver requests that we may make in the future, and, if they do consent, they may do so on terms that are not favorable to us. In the event that we are unable to obtain any such waiver or amendment and we are not able to refinance or repay our Senior Secured Credit Facilities, our inability to meet the covenants or other provisions of the Senior Secured Credit Facilities would constitute an event of default, which would permit the bank lenders to accelerate the Senior Secured Credit Facilities. Such acceleration may in turn constitute an event of default under our senior notes or other indebtedness.

Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019. The notes are general unsecured, senior obligations and are unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year. Prior to March 1, 2015, we may redeem all or a part of the senior notes, at a redemption price equal to 100.00% of the principal amount of the senior notes redeemed plus the applicable premium as of such date, plus accrued and unpaid interest, if any, to the applicable redemption date. After March 1, 2015, we may redeem all or a part of the senior notes for 103.375%, 101.688%, and 100.000% of the principal amount in 2015, 2016 and 2017 and thereafter, respectively.

At March 31, 2014, we were in compliance with the covenants under the Senior Secured Credit Facilities and the indenture governing our 6.75% senior notes.

Consummation of our pending transaction with LCY would constitute a change of control under the indenture governing our 6.75% senior notes, which would result in an event of default under the Senior Secured Credit Facilities. Under the combination agreement with LCY, it is a condition to the parties’ obligations to close the transaction that we obtain the necessary consent such that the combination with the SBC business of LCY will not result in an event of default under our Senior Secured Credit Facilities. We intend to seek the consent of our bond holders such that the combination with the SBC business would not constitute a change of control under the indenture and to satisfy the closing condition.

Based upon current and anticipated levels of operations, we believe that cash flows from operations of our subsidiaries, cash on hand, and borrowings available to us will be sufficient to fund our expected financial obligations, planned capital expenditures and anticipated liquidity requirements, including working capital requirements, our investment in the joint venture with FPCC, debt payments, interest payments, benefit plan contributions and income tax obligations. However, these cash flows are subject to a number of risks and uncertainties, including, but not limited to, earnings, sensitivities to the cost of raw materials, seasonality and fluctuations in foreign currency exchange rates. Because feedstock costs generally represent a substantial portion of our cost of goods sold, in periods of rising feedstock costs, we generally consume cash in operating activities due to increases in accounts receivable and inventory costs, partially offset by increased value of accounts payable. Conversely, during periods in which feedstock costs are declining, we generate cash flow from decreases in working capital. Additionally, our combination agreement with LCY contains restrictions on our incurrence of indebtedness, subject to specified exceptions that include borrowings under the Senior Secured Credit Facilities in the ordinary course.  If we needed borrowings in excess of $10.0 million above what is available to us under the Senior Secured Credit Facilities and LCY did not provide its consent, our ability to fund our financial obligations may be adversely affected.

Going forward there can be no assurance that our business will generate sufficient cash flow from operations or that future borrowings will be available under our senior secured credit facilities to fund liquidity needs and enable us to service our indebtedness. At March 31, 2014, we had $97.3 million of cash and cash equivalents, which includes $54.7 million of cash-on-hand at KFPC, the consolidated joint venture in Asia. As of March 31, 2014, our available borrowing capacity was $213.3 million of which $0

43


 

million was drawn and as of the date of this filing, our available borrowing capacity was $227.8 million, of which $0 million was drawn. Excluding the $54.7 million of KFPC cash, our liquidity at March 31, 2014 amounted to $255.9 million. Our available cash and cash equivalents are held in accounts managed by third-party financial institutions and consist of cash invested in interest bearing funds and operating accounts. To date, we have not experienced any losses or lack of access to our invested cash or cash equivalents; however, we cannot provide any assurance that adverse conditions in the financial markets will not impact access to our invested cash and cash equivalents.

For additional information regarding our Senior Secured Credit Facilities and our 6.75% Senior Notes, see “—Senior Secured Credit Facilities and 6.75% Senior Notes due in 2019—” in Note 6 Long-Term Debt to the condensed consolidated financial statements, which is incorporated herein by reference.

We made contributions of $1.4 million to our pension plan in the three months ended March 31, 2014 and $1.2 million for the three months ended March 31, 2013. We expect our total pension plan contributions for the year ended December 31, 2014 to be $7.2 million. Our pension plan obligations are predicated on a number of factors, the primary ones being the return on our pension plan assets and the discount rate used in deriving our pension obligations. If the investment return on our pension plan assets does not meet or exceed expectations during 2014, and the discount rate decreases from the prior year, higher levels of contributions could be required in 2015 and beyond.

As of March 31, 2014, we had $96.2 million of cash and short-term investments related to foreign operations that management asserts are permanently reinvested. As a result of net operating loss carryforwards, management estimates that no additional cash tax expense would be incurred if this cash were repatriated.

Turbulence in U.S. and international markets and economies may adversely affect our liquidity and financial condition, the liquidity and financial condition of our customers, and our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations. However, to date we have been able to access borrowings available to us in amounts sufficient to fund liquidity needs. Total receivables, net of allowances, for customers located in Italy, Spain, Portugal, Greece and Ireland aggregated approximately $6.6 million at March 31, 2014. We have not incurred to date, nor do we currently expect to incur any material losses associated with these trade receivables.

Our ability to pay principal and interest on our indebtedness, fund working capital, make anticipated capital expenditures and fund our investment in the joint venture with FPCC depends on our future performance, which is subject to general economic conditions and other factors, some of which are beyond our control. “See Part I, Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 for further discussion.

Operating Cash Flows and Liquidity

Due to the seasonal nature of portions of our business, we generally use cash in operating activities in the first quarter. In the first quarter of 2014 and 2013, cash used in operating activities totaled $53.6 million and $20.8 million, respectively. The decline in operating cash flow in the first quarter of 2014 compared to the first quarter of 2013 was primarily the result of the timing of payments of current liabilities and the decline in earnings, partially offset by the effect of sales volume and revenue per ton, which resulted in a smaller increase in accounts receivable in 2014 as compared to 2013.

Investing Cash Flows

Net cash used in investing activities totaled $21.2 million for the three months ended March 31, 2014 and $17.4 million for the three months ended March 31, 2013.

Expected Capital Expenditures. We currently expect 2014 capital expenditures, excluding capital expenditures by the joint venture with FPCC, will be approximately $75.0 million to $80.0 million. Included in this estimate is approximately $29.4 million to comply with the MACT rule, and approximately $16.0 million to $22.0 million for health, safety and environmental and infrastructure and maintenance projects. The remaining anticipated 2014 capital expenditures are primarily associated with projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform.

44


 

We currently anticipate the total FPCC joint venture project construction cost will be at least $200.0 million. We currently estimate that the joint venture’s 2014 capital expenditures will be approximately $110.0 million to $120.0 million. We and FPCC intend to pursue opportunities to obtain debt financing for project costs at the joint venture level. Based on our current assumptions with respect to final project cost, timing and the extent to which the project can be funded through third-party debt financing, we estimate our share of the funding for the joint venture will be approximately $50.0 million of which $41.6 million has been funded through March 31, 2014.

Financing Cash Flows

Our consolidated capital structure as of March 31, 2014 and December 31, 2013 was approximately 57% equity, 39% debt and 4% noncontrolling interest.

Net cash used in financing activities totaled $2.9 million for the three months ended March 31, 2014 compared to net cash used in financing activities of $45.5 million for the three months ended March 31, 2013, representing a period-over-period increase in cash from financing activities of $42.6 million. In the first quarter of 2013, we repaid $96.9 million remaining principal balance of term loans and received $15.2 million from FPCC, which represents their portion of the equity investment in the joint venture.  

Contractual Commitments

Our contractual obligations are summarized in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our annual report on Form 10-K for the period ended December 31, 2013.There have been no material changes to the contractual obligation amounts disclosed in our annual report on Form 10-K for the year ended December 31, 2013.

Off-Balance Sheet Arrangements

We are not involved in any material off-balance sheet arrangements as of March 31, 2014, other than operating leases.

 

 

 

45


 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk.

For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our annual report on Form 10-K for the year ended December 31, 2013. There have been no material changes to the quantitative and qualitative disclosures about market risk disclosed in our annual report on Form 10-K for the year ended December 31, 2013. See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for further discussion.

 

Item 4.

Controls and Procedures.

An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934) was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. As of March 31, 2014, based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective.

There has been no change in our internal control over financial reporting that occurred during the three months ended March 31, 2014 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

46


 

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings.

For information regarding legal proceedings, see Note 10 Commitments and Contingencies, to our condensed consolidated financial statements.

In January 2014, our Belpre, Ohio facility experienced a mechanical equipment failure due to inclement weather that resulted in a release of process solvents into nearby waterways. Applicable authorities were notified, and cleanup activities are underway. Kraton may be required to pay governmental fines or sanctions in excess of $100,000 in connection with this event.

 

Item 1A.

Risk Factors.

Readers of this Quarterly Report on Form 10-Q should carefully consider the risks described in our other reports filed with or furnished to the SEC, including our prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of our financial position, results of operations and cash flows.

The risks and uncertainties in our most recent Annual Report on Form 10-K, are not the only risks that we face. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect our operations. Any of the risks, uncertainties, events or circumstances described therein could cause our future financial condition, results of operations or cash flows to be adversely affected.

 

 

 

47


 

Item 6.

Exhibits.

 

Exhibit
Number

 

 

2.1

 

Combination Agreement, dated as of January 28, 2014 (incorporated by reference to Exhibit 2.1 to Kraton Performance Polymers, Inc.’s Current Report on Form 8-K filed with the SEC on January 28, 2014)

10.1

 

Form of Voting Agreement (incorporated by reference to Exhibit 10.1 to Kraton Performance Polymers, Inc.’s Current Report on Form 8-K filed with the SEC on January 28, 2014)

10.2

  

Form of Kraton Performance Polymers, Inc. Restricted Stock Award Agreement under the 2009 Equity Incentive Plan (incorporated by reference to Exhibit 10.29 to Kraton Performance Polymers, Inc.’s Annual Report on Form 10-K filed with the SEC on February 27, 2014)

10.3

  

Form of Kraton Performance Polymers, Inc. Restricted Stock Unit Award Agreement under the 2009 Equity Incentive Plan (incorporated by reference to Exhibit 10.30 to Kraton Performance Polymers, Inc.’s Annual Report on Form 10-K filed with the SEC on February 27, 2014)

10.4

  

Form of Kraton Performance Polymers, Inc. Restricted Stock Performance Unit Award Agreement under the 2009 Equity Incentive Plan (incorporated by reference to Exhibit 10.31 to Kraton Performance Polymers, Inc.’s Annual Report on Form 10-K filed with the SEC on February 27, 2014)

10.5

  

Form of Kraton Performance Polymers, Inc. Stock Option Award Agreement under the 2009 Equity Incentive Plan (incorporated by reference to Exhibit 10.32 to Kraton Performance Polymers, Inc.’s Annual Report on Form 10-K filed with the SEC on February 27, 2014)

10.6

  

Form of Kraton Performance Polymers, Inc. Special Restricted Stock Performance Unit Award Agreement under the 2009 Equity Incentive Plan (incorporated by reference to Exhibit 10.33 to Kraton Performance Polymers, Inc.’s Annual Report on Form 10-K filed with the SEC on February 27, 2014)

31.1*

 

Certification of Chief Executive Officer under Section 302 of Sarbanes—Oxley Act of 2002

31.2*

 

Certification of Chief Financial Officer under Section 302 of Sarbanes—Oxley Act of 2002

32.1*

 

Certification Pursuant to Section 906 of Sarbanes—Oxley Act of 2002

99.1

 

Form of Shareholder Agreement (incorporated by reference to Exhibit 99.1 to Kraton Performance Polymers, Inc.’s Current Report on Form 8-K filed with the SEC on January 28, 2014)

101*

 

The following materials from Kraton Performance Polymers, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2014, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2014 and December 31, 2013 (Unaudited), (ii) Condensed Consolidated Statements of Operations for the three months ended March 31, 2014 and 2013 (Unaudited), (iii) Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2014 and 2013 (Unaudited), (iv) Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2014 and 2013 (Unaudited), (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2014 and 2013 (Unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (Unaudited).

 

*

Filed herewith.

 

 

 

48


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

KRATON PERFORMANCE POLYMERS, INC.

Date:

May 1, 2014

/s/ Kevin M. Fogarty

 

 

Kevin M. Fogarty

 

 

President and Chief Executive Officer

 

 

 

Date:

May 1, 2014

/s/ Stephen E. Tremblay

 

 

Stephen E. Tremblay

 

 

Vice President and Chief Financial Officer

 

49